Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation

2025-03-09
HONG KONG, Mar 7, 2025 - (ACN Newswire via SeaPRwire.com) - Everest Medicines' stock (1952.HK) surged today, opening higher and maintaining strong momentum throughout the trading day. By market close, the stock had risen 20.12% to HK$60.6, bringing the company's total market capitalization to HK$19.791 billion. This marks its highest level in nearly three and a half years since September 28, 2021, while also successfully surpassing its 2020 IPO issue price of HK$55, reflecting strong investor confidence in its AI-based mRNA platform, dual-engine strategy, and future commercialization prospects.According to the latest updates, Everest Medicines announced yesterday that the first patient has been dosed with the Company’s internally developed personalized mRNA cancer vaccine EVM16 at Peking University Cancer Hospital as part of an investigator-initiated clinical trial (IIT). Following this announcement, the company held an Investor Calls, where it provided detailed insights into its AI-based mRNA platform and pipeline advancements, highlighting progress in neoantigen prediction, vaccine development, and future commercialization strategies.Governments worldwide continue to support mRNA-based oncology research, with leading biopharmaceutical companies such as BioNTech and Moderna achieving breakthroughs in personalized cancer vaccines. Over the next one to two years, several key milestones are expected, particularly in melanoma, pancreatic cancer, and other high-mortality cancers, further reinforcing the therapeutic potential of mRNA-driven oncology treatments.Everest Medicines has established a fully integrated and clinically validated mRNA platform, encompassing antigen design, mRNA sequence optimization, LNP delivery system, and GMP production capabilities. The company holds global rights to its platform and pipeline, which is structured around four key areas: personalized cancer vaccines (PCV), tumor-associated antigen (TAA) vaccines, immune-modulatory cancer vaccines, and in vivo CAR-T therapies. With a comprehensive and differentiated portfolio, Everest Medicines is well-positioned in the rapidly evolving mRNA therapeutic landscape.The success of personalized cancer vaccines depends on the ability to identify the most immunogenic tumor mutations among thousands of genetic alterations. Everest Medicine’s proprietary machine learning based neoantigen prediction algorithm (EVER-NEO-1), uses advanced deep learning technology to precisely select highly immunogenic peptide sequences, optimizing them for mRNA vaccine design.Independent validation has shown that EVER-NEO-1’s neoantigen prediction capability meets or exceeds industry-leading standards. In head-to-head comparisons with MSKCC, a globally recognized neoantigen prediction algorithm, Everest’s model demonstrated superior performance in identifying a broader range of highly immunogenic tumor neoantigens.In preclinical studies, EVM16 demonstrated significant tumor growth inhibition in syngeneic mouse model, with repeated dosing showing favorable safety and tolerability. Preclinical data also showed a synergistic anti-tumor effect when EVM16 was combined with a PD-1 antibody, supporting its potential use in combination therapies in clinical settings.Additionally, Everest is advancing EVM14, its off-the-shelf TAA cancer vaccine, which has achieved key regulatory milestones. The company will submit an investigational new drug application for its TAA vaccines in China and the United States in 2025. One of EVM14’s key advantages is its ability to induce long-term immune memory and prevent tumor recurrence. In preclinical studies, 13 out of 15 mice treated with EVM14 experienced complete tumor regression, with no tumor regrowth even after re-exposure to tumor cells. Additionally, EVM14 has shown enhanced anti-tumor efficacy when combined with PD-1 inhibitors, further supporting its clinical potential.Everest’s mRNA platform extends beyond oncology, with the company advancing immune-modulatory cancer vaccines and in vivo CAR-T therapies. The in vivo CAR-T program, leveraging mRNA/tLNP technology, has successfully achieved T cell transfection and CAR expression in non-human primate models. Compared to conventional CAR-T therapies, Everest’s in vivo CAR-T offers significant advantages, including lower production costs, enhanced safety, no need for lymphodepletion, and potential for outpatient treatment administration. Early data also suggests promising applications in refractory systemic lupus erythematosus (SLE), demonstrating its broader therapeutic potential.Speaking at today’ s Investor Calls, Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines, stated: "Everest Medicines has successfully transitioned from a license-in-driven model to a dual-engine strategy. The establishment of our proprietary mRNA platform marks a significant milestone, strengthening our in-house R&D capabilities and serving as a key driver of future growth. At the same time, we are accelerating the commercialization of our core products and remain committed to achieving our strategic goal of exceeding RMB 10 billion by 2030. Everest Medicines is poised to unlock even greater long-term value and advance toward the forefront of global biopharmaceutical innovation."From a capital markets perspective, Everest Medicines’ AI-based mRNA platform integrates cutting-edge antigen selection, mRNA sequence optimization, and industrial-scale production capabilities, positioning it as a strong player in the global mRNA therapeutics space. Everest Medicines is the first biopharmaceutical company in China to advance an AI-based personalized mRNA cancer vaccine into the clinical stage. BOCOM International has recognized Everest Medicines as a key innovator in mRNA cancer therapeutics, highlighting its strong pipeline catalysts, significant revenue potential, and substantial valuation upside. Everest is well-positioned to strengthen its leadership in AI-enabled mRNA innovation and drive new global collaborations in the biopharmaceutical sector. Copyright 2025 ACN Newswire via SeaPRwire.com.
More

uSMART Securities Initiates Coverage on NAAS Technology with a ‘Buy’ Rating and a Target Price of US$3.2 per ADS, Citing Industry Leadership and Profitability Outlook

2025-03-09
HONG KONG, Mar 7, 2025 - (ACN Newswire via SeaPRwire.com) - uSMART Securities recently initiated coverage on NAAS Technology Inc. (NASDAQ: NAAS) with a “Buy”rating, setting a target price of US$3.20 per ADS, compared to the current trading price of US$1.15 per ADS as of March 7, 2025. The firm’s investment thesis is driven by the following key factors:1. Industry Leadership in the EV Charging PlatformNAAS is a leading electric vehicle (EV) charging platform in China, boasting a strong market presence in both network scale and user base. As of Q3 2024, the company had connected approximately 100,000 charging stations and 1.15 million chargers, accounting for 35% of the total public chargers in China. its platform served approximately 14 million transaction users, covering 50% of the country’s EV owners. In Q3 alone, NaaS facilitated 1.3 billion kWh of charging volume and 50 million transactions. With its robust supply and demand integration, uSMART Securities expects NaaS to further enhance network efficiency and maintain its market leadership.2. Profitability Breakthrough through an Asset-Light Business ModelNAAS’s strategic focus on asset-light, platform-based business model is accelerating the path to profitability. In 2024, the company shifted its focus to platform-based charging interconnectivity services, leading in substantial margin growth. Gross profit margin surged from 19% in 4Q 2023 to 57% in 3Q 2024, while non-IFRS net profit margin improved dramatically from -525% to 46% over the same period. This accelerated NAAS’ path to profitability ahead of schedule. Looking ahead, as economies of scale continue to expand, NAAS is expected to further improve its financial performance, transitioning from a cash-burning startup into a fundamentally driven growth company.3. AI- Driven Data Monetization OpportunitiesNAAS is uniquely positioned to capitalize on data monetization in the AI era. With 35% of public chargers and 50% of EV users in China, the company has developed the NAAS Energy Fintech (NEF) system, leveraging proprietary AI algorithms to explore potential opportunities:- Dynamic Pricing: Adjusts service fees in real-time based on demand and electricity prices, enhancing price elasticity and increasing customer retention.- Intelligent Asset Management: Uses AI-driven site selection and real-time monitoring to improve charging station efficiency and utilization.- Grid Load Balancing: Supports governments and regulators in peak shaving and demand responseWith China's EV adoption accelerating into 2025, NAAS is poised to further explore commercialization opportunities in these areas.4. Attractive Valuation Amid Sustainable ProfitabilityNaaS presents a compelling valuation, particularly as it approaches full-year break-even in 2025. This shift in profitability allows for a transition in valuation methodology from a startup-focused P/S ratio to a broader mix of P/S, PEG, and P/E multiples. Based on projected 2025 revenue of RMB 229 million and a 1.4x P/S ratio aligned with US-listed peer companies, uSMART Securities gives NAAS a “Buy” with a target price of US$3.20 per ADS. Copyright 2025 ACN Newswire via SeaPRwire.com.
More

雲頂新耀股價創3年新高 AI+mRNA賦能管線重塑估值

2025-03-08
香港, 2025年3月7日 - (亞太商訊 via SeaPRwire.com) - 今日，雲頂新耀（1952.HK）股價強勢上漲，高開後持續走強，全天維持上升趨勢，截至收盤上漲20.12%，報60.6港元，公司總市值攀升至197.91億港元。創下自2021年9月28日以來的近三年半新高，並成功突破2020年IPO發行價55港元。據最新消息，雲頂新耀於昨日宣佈其自主研發的mRNA個性化腫瘤治療性疫苗（PCV）EVM16在中國完成首例患者給藥，該疫苗正在開展研究者發起的臨床試驗（IIT）。在這一進展公佈後，雲頂新耀隨後召開中英文投資者交流會，詳細介紹AI賦能mRNA平台的技術突破及研發管線最新動態，重點展示公司在新抗原預測、疫苗開發及未來商業化方面的最新進展。近年來，全球對mRNA技術在癌症治療中的應用給予高度關注，多國政府相繼出台政策支持該領域發展。以BioNTech、Moderna為代表的企業已在個性化腫瘤疫苗領域取得突破，預計未來1-2年將迎來多個重要里程碑，尤其是在黑色素瘤、胰腺癌等高難度癌症治療中的應用，進一步驗證了mRNA癌症疫苗的潛力。雲頂新耀已建立本地化、經臨床驗證的mRNA平台，涵蓋從抗原設計、mRNA序列優化、LNP遞送技術到GMP生產的全產業鏈能力，並擁有全部全球權益。基於該平台，公司佈局了個性化腫瘤治療性疫苗（PCV）、腫瘤相關抗原疫苗（TAA）、免疫調節腫瘤疫苗和自體生成CAR-T四大研發方向，整體佈局完備，具備顯著的差異化競爭力。EVM16作為雲頂新耀個性化腫瘤治療性疫苗（PCV）的代表性項目，已在北京大學腫瘤醫院完成首例患者給藥。其核心優勢在於雲頂新耀基於深度學習的自研新抗原預測算法-「妙算」系統（EVER-NEO-1）來篩選新抗原，可精准篩選高免疫原性肽段，優化mRNA疫苗抗原設計，提升免疫應答效果。獨立驗證顯示，EVER-NEO-1的新抗原預測能力達到或超越行業領先水準，並在頭對頭研究中優於MSKCC算法，可識別更多具備強免疫原性的腫瘤新抗原。臨床前研究表明，該算法預測的新抗原可有效激發T細胞免疫，並在小鼠腫瘤模型中展現更優療效。此外，EVM16與PD-1抗體聯合使用可增強T細胞活化，產生協同抗腫瘤作用，為未來聯合免疫療法提供了有力依據。在猴子非人靈長類實驗中，EVM16展現劑量依賴性免疫原性，加強針可進一步增強免疫應答並維持長期免疫保護，同時在臨床前毒理研究中展現良好安全性。除EVM16外，雲頂新耀正在推進現貨型TAA癌症疫苗EVM14的臨床開發，並計劃於2025年在中美兩地遞交新藥臨床試驗申請。EVM14的一大突破在於可誘導免疫記憶，防止腫瘤復發。在動物實驗中，13/15只小鼠在EVM14治療後腫瘤完全消退，即使再次接種腫瘤細胞，仍未出現復發，驗證了其長期保護作用。同時，EVM14在聯合PD-1抗體使用時展現出更強的抗腫瘤活性，進一步支持其在臨床應用中的潛力。雲頂新耀的mRNA平台還覆蓋免疫調節腫瘤疫苗和自體生成CAR-T。其中，自體生成CAR-T療法基於mRNA/tLNP平台，可在體內直接生成CAR-T細胞，突破傳統CAR-T的局限性。相較于傳統CAR-T療法，mRNA體內CAR-T具有更低的生產成本、更高的安全性、無需清除淋巴、不依賴住院治療等優勢。此外，該技術還在系統性紅斑狼瘡（SLE）等自身免疫疾病中展現潛力，為CAR-T療法拓展至非腫瘤適應症提供了全新可能。雲頂新耀CEO羅永慶在今日投資者交流會上表示：「雲頂新耀已成功從依賴授權引進（license-in）的模式，轉型為自主研發與授權引進並行的雙輪驅動模式，建立了具有自主知識產權的mRNA平台。這一里程碑不僅強化了公司的自研創新能力，也將成為未來增長的重要引擎。與此同時，我們正加速推進核心產品的商業化進程，並堅定執行2030年前核心產品銷售突破100億元人民幣的目標。隨著mRNA平台和自體生成CAR-T療法的持續突破，雲頂新耀的長期價值將進一步釋放，助力公司邁向全球生物醫藥創新的前沿。」從資本市場的角度來看，雲頂新耀的mRNA平台整合了AI驅動的抗原篩選、mRNA序列優化及產業化能力，具備較強的全球競爭力和商業化潛力。雲頂新耀是國內首個將由AI驅動的mRNA腫瘤治療性疫苗進入臨床階段的生物製藥公司。交銀國際在研報中重點推薦雲頂新耀，認為其創新管線催化劑豐富，盈利增長潛力明確，具備較大的估值修復彈性。隨著EVM16的臨床推進、EVM14的全球化申報進展以及體內CAR-T療法的持續突破，雲頂新耀的AI+mRNA佈局不僅強化了其行業領先地位，也有望成為國際BD合作的重要籌碼，在全球創新藥競爭格局中佔據更有利的位置。 Copyright 2025 亞太商訊 via SeaPRwire.com.
More
業聚醫療連續四年實現收入增長 達1.64億美元創新高 純利達3,970萬美元 建議派發末期股息每股10港仙 ACN Newswire

業聚醫療連續四年實現收入增長 達1.64億美元創新高 純利達3,970萬美元 建議派發末期股息每股10港仙

2025-03-08
業績亮點：- 收入同比增長6.6%達164.1百萬美元創新高。- 銷量達1.7百萬件，其中1.5百萬件為自有產品，同比增長4.8%。- 毛利上升7.5％至114.5百萬美元，毛利率提升至69.8％；公司擁有人應佔利潤達39.7百萬美元。- 董事會建議派發末期股息每股10港仙，派息比率為26.7％。- 集團的財務狀況穩健，年末現金及銀行結餘為248.6百萬美元，擁有充足資金支持日後的併購計劃。- 在新收購的印尼及韓國分銷商推動下，加上來自直銷業務的內生增長，亞太區市場收入同比增長43.7％，而美國及中國市場亦於2024年下半年呈現復甦跡象。- 集團於2023年11月收購德國公司eucatech AG後，已為其產品在捷克、意大利、馬來西亞、沙特阿拉伯、西班牙、瑞士、阿聯酋及越南完成註冊。香港, 2025年3月7日 - (亞太商訊 via SeaPRwire.com) - 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929）今天宣佈截至截至2024年12月31日止年度（「年度」）的全年業績。儘管業務環境充滿挑戰，但集團仍創下收入新高，並錄得穩健純利。受到下半年美國市場銷售回升，以及亞太區市場的持續增長帶動，集團的收入達164.1百萬美元，較去年增長6.6%。若撇除匯兌的影響，收入更同比增長8.7%。毛利上升7.5％至114.5百萬美元，毛利率亦微升至69.8％。回顧年度內，集團積極整合在2023年底收購的三間公司的旗下業務，為長遠達到理想業績奠定基礎。儘管相關整合工作短暫產生額外費用，導致公司擁有人應佔利潤錄得39.7百萬美元（2023年：45.1百萬美元），然而這些工作預計能於未來創造顯著的協同效應。撇除上述的額外開支，集團的三大核心經營開支，包括銷售及分銷開支、一般及行政開支以及研發開支，維持在與去年相若的水平。於2024年12月31日，集團的財務狀況穩健，現金及銀行結餘達約248.6百萬美元（2023年：255.8百萬美元）。經審慎評估集團未來資金需求後，董事會建議派發末期現金股息每股10港仙（2023年：每股10港仙），以答謝股東及投資者一直以來的支持。業聚醫療董事長、執行董事兼首席執行官錢永勛先生表示：「2024年，業聚醫療團隊迎難而上，在強化研發、生產、供應鏈、臨床、監管、質量、銷售及市場推廣等領域不遺餘力。其中，我們在印尼和韓國新收購的分銷商迅速為集團帶來貢獻，推動了我們在亞太市場的表現。與此同時，我們也專注於eucatech AG的產品註冊工作，並取得八個國家註冊批准，並將會在更多國家取得進展。2025年將迎來業聚醫療成立25週年。過去，我們已成功在全球市場建立了良好聲譽，以及持續數年達到收入增長。憑藉不懈的創新、強大的全球佈局以及領先的產品組合，我們有信心能再創高峰。展望未來，我們會繼續致力改善患者的治療效果，同時為股東創造長遠價值。」廣泛的銷售網絡推動亞太地區及歐洲、中東及非洲地區增長業聚醫療透過覆蓋全球70多個國家和地區的廣泛銷售網絡銷售產品，並在主要市場保持均衡的收入比例。受惠於印尼及韓國新收購的分銷商帶來的外部增長，以及馬來西亞、新加坡、香港、越南及印度市場的強勁內生增長，亞太區市場於回顧年度成為集團的主要增長動力，收入增加43.7％至52.2百萬美元。其中，最新一代刻痕球囊Scoreflex TRIO自2024年初在馬來西亞推出後，銷量迅速攀升。此外，來自歐洲、中東及非洲的收入同比增長7.9%，達到39.2百萬美元，主要由集團的自有球囊產品在直銷市場（如德國及西班牙）以及分銷市場（如捷克、斯洛伐克及英國）的銷量增長帶動。中國內地及美國市場於2024年下半年均取得顯著改善。隨著京津冀「3+N」聯盟帶量採購（「帶量採購」）在各省陸續推行，以及集團採取更積極的營銷策略，Scoreflex的銷量增長勢頭良好。因此，下半年中國市場的表現有所改善，全年收入達到20.7百萬美元。同時，在集團與美國分銷商雅培進行積極商討後，美國市場的收入逐漸回升。 尤其是高售價產品Scoreflex NC，其下半年的銷量為上半年的逾三倍，帶動美國市場的收入達到17.5百萬美元。日本市場的收入則為34.4百萬美元。多元化創新產品：涵蓋獲批及即將進行臨床試驗階段的產品截至2024年12月31日，業聚醫療在全球主要司法管轄區擁有超過240項授權專利及公佈專利申請，並擁有逾50款獲批產品。於2024年，集團在產品註冊及臨床試驗方面取得重大進展，包括：- Teleport Neuro獲得國家藥監局批准，Teleport XT、JADE PLUS 14/18/35 OTW、Sapphire Ultra及Sapphire NC Ultra 獲得FDA批准；以及Sapphire Ultra、Sapphire NC Ultra、Xtenza和Teleport XT獲得CE標誌；- 向國家藥監局提交導引導管及Jade PTA型號擴充的註冊申請，及向PMDA提交Scoreflex QUAD及Teleport Glide註冊申請；- 在中國境內進行的Scoreflex TRIO臨床試驗已完成病人入組，並於2025年1月向國家藥監局提交申請；- 於2024年第四季在美國展開Sapphire 3臨床試驗的病人入組，預計將於2026年第一季提交申請批准。繼2023年底收購eucatech AG後，集團積極在多個國家為其產品eucaLimus（藥物洗脫支架）、Support C（冠狀動脈藥物塗層球囊）及VITUS（外周藥物塗層球囊）辦理註冊。上述一種或多種產品已於捷克、意大利、馬來西亞、沙特阿拉伯、西班牙、瑞士、阿聯酋及越南等地完成註冊，而於香港、印尼及新加坡的註冊申請亦有待批准。此外，為了在MDR制度下為上述產品續領CE標誌，集團已開展臨床登記，並聘請國際知名的關鍵意見領袖（「KOL」）臨床醫師擔任該等登記的首席調查專家。同時，集團繼續投資於新產品管線，例如抽吸導管、雙腔導管、外周刻痕球囊及鞘管，並預期於2025年向各監管機構提交該等產品的註冊申請。為迎合「介入無植入」的趨勢，集團亦投資於自有紫杉醇藥物塗層球囊，預計於2025年第四季在日本展開臨床試驗。本年度，合資企業OrbusNeich P＆F致力推進TricValve在亞太區兩大市場的臨床研究。在中國境內的臨床試驗已於2024年4月開始，而在日本的PMDA臨床試驗方案批准預計將於2025年底完成。除自有產品外，集團與一家中國製造商訂立分銷協議，自2024年12月起在香港及澳門分銷其血管內超聲波（IVUS）導管，從而令產品組合更為多元化。嚴格的生產程序確保卓越產質截至2024年12月，業聚醫療的球囊年產能達約2百萬件，支架年產能達約60,000件，並採用嚴格的品質管理系統及維持ISO 13485，以保障產品品質。其中，eucatech AG於2024年下半年通過ISO 13485再認證審核，而深圳基地亦於2024年6月取得ISO 14001及ISO 45001認證，突顯集團對可持續發展的承諾。此外，集團於中國杭州建設旗下最大研發及製造設施的工程於年內進展順利。集團目前致力提升其自動化水平，以減低勞動力需求及提高營運效率，最終降低整體營運成本。新設施預計於2027年投產，投產後產品年產能將增加2.4百萬件。錢先生總結：「展望2025年，有見亞太地區和歐洲、中東及非洲地區增長強勁，加上美國及中國市場持續復甦，我們對集團的前景保持審慎樂觀。過去25年，我們的成功基石建立在持續創新、拓展產品線及鞏固銷售網絡之上。這些努力，加上整合收購業務帶來的協同效應，讓我們準備就緒，把握未來的商機。我們的財政實力雄厚，也將有助我們把握行業整合的機遇，進行策略併購，藉此增強技術儲備及擴大產品組合。為了在醫療器械市場中達到穩定增長，我們將更重視可持續發展，以迎合瞬息萬變的醫療行業格局，同時貫徹實踐改善患者治療效果的使命。」關於業聚醫療集團控股有限公司業聚醫療是一家主要的全球醫療器械製造商，專門生產用於經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）的介入器械。本集團總部位於中國香港，產品銷往全球超過70個國家和地區。集團亦積極將業務擴展至神經血管介入及結構性心臟病領域。憑借擁有逾20年產品開發經驗的內部研發團隊，本集團已開發出世界領先的專有技術。如需瞭解詳情，請訪問集團官網：https://orbusneich.com/ Copyright 2025 亞太商訊 via SeaPRwire.com.
More
東信營銷科技：中國AI營銷龍頭斬獲多模態雙備案 技術實力獲國家級認證 ACN Newswire

東信營銷科技：中國AI營銷龍頭斬獲多模態雙備案 技術實力獲國家級認證

2025-03-08
香港, 2025年3月7日 - (亞太商訊 via SeaPRwire.com) - 3月6日晚間，中國AI營銷龍頭 - 東信營銷科技（以下簡稱「東信」）宣佈集團旗下「營賽洞見」多模態大模型已正式通過廣東省互聯網資訊辦公室（簡稱「網信辦」）生成式人工智能服務備案審批，成為國內首個通過多模態備案的營銷垂直大模型。此前該模型已於2024年4月獲中央網信辦大模型備案，此次多模態備案的達成，意味著東信營銷科技成為行業首個實現了大模型「雙備案」的AI營銷公司。此次雙重備案標誌著東信營銷科技在技術合規性、安全性及應用價值等方面獲得國家權威認可。根據《生成式人工智能服務管理暫行辦法》，備案審批是對大模型技術安全合規、技術能力及社會價值的重要認證。通過雙重備案的企業將具備行業准入資質，可加速技術商業化進程。備案已成為行業准入門檻，率先通過備案的企業可搶佔市場先機。通過備案後，依託營賽洞見的多模態生成能力，東信營銷科技有望加速MAA營銷智能體和MarRAG技術的研發迭代，強化自身在AI營銷領域的技術壁壘，吸引更多客戶和生態夥伴，加速行業合作與應用落地從而產生規模化經濟效益。大模型技術實力獲國家認可多模態備案是指對能夠在處理和交互中綜合運用文本、圖像、聲音等不同數據類型的人工智能模型進行官方認證和備案的過程。東信營銷科技的「營賽洞見」大模型在獲得國家網信辦多模態備案的過程中，展現了卓越的技術實力。通過備案不僅標誌著大模型在技術上的成熟，亦代表著其符合國家關於數據安全、隱私保護等方面的高標準要求。東信「營賽洞見」大模型在數據、場景、模型、算力四大核心領域擁有顯著優勢。1.數據優勢：基於2300億行業數據，高質量數據處理和高精度計算，打造大規模、高質量的營銷垂域大數據資產庫。2.場景優勢：覆蓋300+品類的全鏈路營銷場景，支撐分析洞察、內容策劃、內容生成、營銷策略等152個AIGC應用場景。3.模型優勢：7大類77個算法模型搭載五大技術中台，構成強大、高效、精准的營銷垂域技術底座。4.算力優勢：調用華為雲的鯤鵬（昇騰）架構提供強大算力和高精度計算，確保大模型在實際應用中的穩定性、可靠性。深耕AI營銷，助力企業產業升級營賽大模型憑藉卓越的多模態生成能力、AI技術實力、行業大數據支撐及完善的安全管理體系，在已通過中央網信辦備案的超302個生成式AI大模型中脫穎而出，成為率先通過備案的垂直領域AI營銷大模型。本次成功通過多模態備案，不僅顯示了公司在AI營銷領域的競爭力，也成為了其他垂直領域大模型的技術典範。據了解，東信AI營銷大模型的圖像模態技術曾在第十五屆中國航展中得到全面應用，為航展的宣傳報導注入了AI先鋒視覺和多元風格，成為航展創意海報背後的「黑科技」。以營賽洞見為代表的營銷垂直大模型的應用，不僅能為企業帶來更多元、更高效的營銷手段，也為整個行業的創新發展注入了新的活力。國家「人工智能+」戰略的推進，為AI技術落地帶來了顯著的政策紅利。隨著更多企業通過備案，大模型競爭將從「參數比拼」轉向「應用深耕」。東信集團首席架構師盧工表示：「備案不是終點，而是AI賦能客戶營銷增長的起點。唯有技術與創新並重，才能贏得長遠發展。」伴隨人工智能技術的不斷發展和完善，東信營銷科技的營賽洞見AI營銷大模型有望在更多行業中得到應用和推廣，為各行業的智能化轉型和發展帶來新的機遇和動力。 Copyright 2025 亞太商訊 via SeaPRwire.com.
More
世界備份日將至 – Synology群暉科技發表全新的資料保護解決方案 提升香港企業級資料韌性 ACN Newswire

世界備份日將至 – Synology群暉科技發表全新的資料保護解決方案 提升香港企業級資料韌性

2025-03-08
圖1. Synology 群暉科技 在香港發布全新ActiveProtect 備份專用一體機。圖片下載：http://bit.ly/3FmNlo0香港, 2025年3月7日 - (亞太商訊 via SeaPRwire.com) - Synology 群暉科技針對香港企業資料保護市場，推出ActiveProtect備份專用一體機，助力企業快速部署，提升資料防護能力，應對勒索病毒攻擊、資料洩漏及業務中斷風險。隨著世界備份日的臨近，Synology群暉科技也呼籲中型至大型企業需要更積極防範資料損失、洩漏和勒索病毒的事件發生。作為私有雲解決方案的領導者，Synology 已獲全球逾半數《財富》500 強企業信賴，管理超過 520 EB（艾位元組）數據，覆蓋 1300 萬部伺服器，並累積保護超過2500萬個工作負載，不僅為業界私有雲龍頭，也確各產業的業務連續性及資料儲存安全性。香港企業資料安全形勢嚴峻 急需強化防護2024年，香港不少企業頻繁遭受網絡攻擊，導致大量個人資料外洩，當中有非牟利機構遭遇黑客攻擊，引致大量數據被盜取，受影響的個人資料更以數十萬計。同年，亦有私營機構遭勒索軟件入侵，導致大量客戶及 內部員工資料資料遭到洩漏。這些事件突顯企業需建立完善的資料備份與防護機制，以防範網絡威脅。ActiveProtect備份專用一體機：企業級資料安全，資料韌性一次到位面對日益增長的網絡安全威脅及資料管理複雜性，Synology 對此提出全新的資料保護解決方案 - ActiveProtect備份專用一體機。這可為企業打造高效、簡便、經濟的資料保護方案。其產品功能將從以下三大核心能力切入：強化勒索病毒防護透過先進安全協議確保數據不可變性，並利用氣隔備份（air-gapped backup）隔離數據，防範惡意篡改與未經授權存取。集中化管理與監控透過單一管理介面監控多達 150,000 個工作負載，統一管理備份策略、執行異地存取及還原，提升資料管理效率。極致成本效益相較傳統解決方案，ActiveProtect 的實施成本僅為 20%，更提供三部伺服器的免費授權，降低企業資料保護門檻。Synology資深區域銷售經理Suk Mi Eun 表示：「資料是企業最重要的資產，而打造具備永續的資料韌性環境更尤其重要。」他進一步指出：「企業對可擴展、安全、易用的備份解決方案需求從未如此迫切，ActiveProtect 備份專用一體機正是為此而生。我們期待這款產品能幫助香港企業更輕鬆地保護他們最有價值的資產。」高效還原能力 確保業務不中斷本次發表會現場，Synology 展示了 ActiveProtect 的資料即時還原能力，涵蓋日常故障修復至災難應對，確保企業能夠迅速恢復運營，降低停機時間，保障關鍵業務穩定運行。簡化部署 擺脫傳統備份困境傳統備份方案通常涉及多種硬件設備及複雜授權機制，導致高昂軟件成本及難以預測的儲存開銷。ActiveProtect備份專用一體機以節點為基礎的授權模式，三部伺服器可免費授權，使企業能更精確掌控成本並同時獲得可靠、安全的的資料保護，確保為香港企業帶來強大的資料防護策略。圖2. ActiveProtect備份專用一體機，現可透過 Synology 全球官方合作夥伴和經銷商選購。欲了解更多ActiveProtect 備份專用一體機詳情或有任何需求， 歡迎至Synology群暉科技官網或聯繫hk.event@synology.com關於 Synology 群暉科技成立於 2000 年，Synology 專注於資料管理領域，提供資料儲存、備份、檔案協作、影像監控管理以及網路架構解決方案，目前在全球已累積超過 1000 萬名用戶，並在網路儲存設備 （NAS）專業使用者及企業市場取得領先地位。隨著資料成為各產業轉型核心，未來 Synology 將持續協助全球企業妥善管理、保護每一份資料，簡化 IT 管理流程。媒體聯繫窗口：Sandra Soh (Synology Regional Marketing）Email : sandrasoh@synology.com聯繫電話：+886 0905027104Andico Tsui (Senior Account Manager of SPRG)Email: andico.tsui@sprg.com.hk聯繫電話：+852 2114 4346 / 6902 3831 Copyright 2025 亞太商訊 via SeaPRwire.com.
More

Chery Auto Launches an IPO on HKEX – Fundamentals Driving Long-term Value Growth

2025-03-07
HONG KONG, Mar 5, 2025 - (ACN Newswire via SeaPRwire.com) - Since 2024, the Chinese automotive industry has witnessed a wave of domestic brands replacement. With the dual drivers of the booming new energy vehicle market and sustained national policy support, domestic brands have achieved significant advances against international brands by means of new energy transformation, coordinated efforts in domestic and international markets, technological innovation, and global expansion, resulting in a continuous increase in market share. As Chinese domestic passenger car brands rise in the global market, the capital market is likely to recognize the intrinsic value of Chinese automakers. Chery Automobile, which submitted its application to the Hong Kong Stock Exchange on February 28, 2025, presents a unique investment opportunity.Founded in 1997, Chery Automobile has long led the industry in innovation and deep international market penetration, achieving comprehensive global business coverage and industry-leading sales. This has cemented its solid position in China's domestic passenger car market. According to Frost & Sullivan, based on global sales for the nine months ended September 30, 2024, Chery Automobile is the second-largest domestic passenger car company in China and 11th largest passenger car company globally.Reinforced Innovation to Establish Core Technological CompetitivenessUpholding the development philosophy of “Building the Enterprise through Technology,” Chery Automobile has been always regarding technological innovation as the core of its business growth. The Company has established a multi-tier and comprehensive R&D system, including the Kaiyang collaborative research initiative, Stellar Lab (core technology research and development platform), and research and development centers located in China, Europe, South and North America, and Southeast Asia.Supported by this robust R&D system and strong research capabilities, Chery Automobile has pursued a technology strategy of “Dual Strategy of ICE (internal combustion engine) vehicles and NEVs,” and achieved technological synergies between ICE vehicle and NEV models. In the field of ICE technology, the Company produced China’s first self-develop proprietary ICE engine for passenger vehicle in 1999; its in-house developed Chery Power 8-speed automatic transmission was the first proprietary 8AT transmission with full intellectual property rights in China. In the field of new energy vehicle hybrid system technology, the Company’s high-performance hybrid engine boasts industry-leading thermal efficiency and the REEV engine can achieve an oil-to-electricity conversion efficiency of 3.7 kWh/L, ranking among the best in the industry, while its hybrid DHT’s maximum mechanical efficiency in pure electric mode is among one of the highest globally.To promote intelligence technologies for NEVs to the next level and accelerate the adoption of intelligence solutions for ICE vehicles, Chery Automobile is committed to providing cost-effective intelligence solutions to users of both ICE vehicles and NEVs, such as its intelligent cockpit system and applications featuring smooth connectivity, personalized intelligence and comprehensive functions across China and overseas markets. In the first nine months of 2024, the percentage of its passenger vehicles equipped with L2 and above intelligent driving solutions reached 50.7%.Rapid Growth Supported by a Diverse Shareholder BasePowered by its exceptional technological advantages, Chery Automobile's diverse range of models has gained widespread market approval, resulting in soaring sales. In the first nine months of 2024, the Company's passenger car sales increased by 51.8% compared to the same period in 2023, leading the growth among the world's top 20 passenger car companies. Moreover, Chery Automobile was the only passenger vehicle company among the global top 20 to achieve a sales volume increase over 30.0% for both NEVs and ICE vehicles and in both China and overseas markets.The rapid business growth has translated into outstanding financial performance. In the first nine months of 2024, Chery Automobile achieved revenues of approximately RMB 182.154 billion, marking a 67.7% year-on-year increase. Net profit reached about RMB 11.312 billion, a year-on-year growth of 58.5%. The return on equity (ROE) was 81.6%. As of September 30, 2024, the Company had cash and cash equivalents totaling RMB 41.938 billion, indicating robust capital reserves.Previously, Chery Automobile has gone through several rounds of strategic financing, forming a diversified shareholder layout. This includes state-owned entities such as Anhui Credit Financing Guaranty Group Co., Ltd., Wuhu Investment Holding Co., Ltd., Bohai Industrial Investment Fund Management Co., Ltd., Qingdao Urban Investment International Development Group Co., Ltd., and Changshu Port Development Construction Co., Ltd., as well as renowned publicly-listed companies and investment institutions like Luxshare Investment (HK) Limited, CATL, Gotion High-Tech, and so on, providing substantial financial and resource support to the Company.In 2024, Chery Automobile's outstanding performance in multiple dimensions, including sales volume, revenue, profit, new energy vehicles, fuel vehicles, and exports, has accumulated sufficient momentum for landing on the international capital market. A Hong Kong listing will not only help the Company establish a long-term capital replenishment channel but also benefit the activation of its equity incentive mechanism to maximize its value potential. Copyright 2025 ACN Newswire via SeaPRwire.com.
More

奇瑞汽車遞表港交所：全球化與新能源轉型雙輪驅動 開啟新一輪價值躍升

2025-03-06
香港, 2025年3月3日 - (亞太商訊 via SeaPRwire.com) - 隨著全球汽車工業向電氣化、智能化方向升級，中國汽車品牌正以驚人的速度崛起，成為全球市場的重要參與者。其中，奇瑞汽車作為中國自主品牌頭部企業，更是這一過程的重要推動者。2月28日，奇瑞汽車向港交所遞交上市申請，開啟國際資本化新征程，有望成為近年來港股市場最大體量的車企IPO之一。奇瑞汽車主要設計、開發、製造和銷售多樣化且不斷擴展的乘用車產品組合，通過多年行業創新及國際深耕，已發展成為全球領先的乘用車公司。根據弗若斯特沙利文的資料，以截至2024年9月30日止九個月的銷量計算，公司是中國第二大自主品牌乘用車公司和全球第十一大乘用車公司。自主乘用車龍頭 國內國外市場齊發力奇瑞汽車成立於1997年，經過近30年的發展，積累了全面的體系化能力和深厚的技術專長，為其打造強勁的產品力奠定了堅實根基，使其能夠根據市場趨勢，不斷推出符合市場需求的產品，形成奇瑞、捷途、星途、iCAR和智界5大定位不同消費群體的品牌，受到了消費者的廣泛認可。根據全球消費者洞察和市場研究公司君迪的排名，在2023年和2024年中國新車質量研究中，奇瑞品牌連續兩年位居中國自主乘用車品牌第一。於中國市場，奇瑞汽車凭借领先的產品力、多元化的產品組合和強大的品牌勢能，實現銷量的持續增長。2024年9月30日首九個月，公司中國乘用車銷量同比增長61.9%，新能源汽車銷量同比增長246.5%，同期燃油車和新能源汽車銷量的同比增速位居中國前十大乘用車公司之首。於國際市場，奇瑞汽車早在2001年就開始業務出海，經過二十餘年的佈局，已在全球範圍建立研發、生產及銷售網絡，實現了從「產品出口」到「本地化運營」的進階。依託全球佈局的产业链，奇瑞汽車能夠為當地市場提供定制化的產品和服務，使其能夠在不同市場實現快速擴張。根據弗若斯特沙利文的資料，自2003年起，公司連續22年在中國自主品牌乘用車公司中乘用車出口量排名第一，在歐洲、南美、中東等多個主要乘用車市場的銷量中名列前茅。擁抱新能源行業發展機遇 加速釋放業績彈性當前，全球汽車行業正加速向新能源、智能化方向轉型。根據弗若斯特沙利文預計，全球新能源汽車滲透率將由2023年18.9%提升至2030年47.0%。奇瑞汽車積極擁抱行業趨勢，從技術、產品序列多方面佈局，不斷完善新能源車型矩陣，完成新能源品牌矩陣向高端拓展，進一步提升了品牌價值。2024年首九個月，公司新能源汽車銷量同比增長231.7%，在全球前二十大乘用車公司中排名第一。新能源領域的佈局不但豐富了奇瑞汽車的產品矩陣，也為其業績增長提供了強大動力。2022年、2023年以及2024年首九個月，公司收入分別為926.2億元（「人民幣」，下同）、1,632.1億元及1,821.5億元，2023年及2024年前9個月同比分別增長76.2%及67.7%；實現利潤分別為58.1億元、104.4億元及113.1億元，2023年及2024年首九個月同比分別增長79.9%及58.5%。隨著奇瑞汽車新能源業務的持續推進，其或將釋放更大的業績彈性。總體而言，作為中國自主品牌的領軍者，奇瑞汽車通過多元化的品牌戰略、全球化的市場佈局和新能源轉型，已成為中國汽車工業的一張名片。此次赴港上市，不僅是公司從「市場全球化」邁向「資本全球化」的重要一步，也是中國汽車工業全球化進程中的關鍵里程碑，有望給整個中國汽車行業帶來積極而深遠的影響。 Copyright 2025 亞太商訊 via SeaPRwire.com.
More
Exceptional Presence of 24 Hong Kong Innovators Mesmerised Mobile World Congress Audience ACN Newswire

Exceptional Presence of 24 Hong Kong Innovators Mesmerised Mobile World Congress Audience

2025-03-06
HONG KONG, Mar 6, 2025 - (ACN Newswire via SeaPRwire.com) - Hong Kong Science and Technology Parks Corporation (HKSTP) joined the Hong Kong Trade Development Council (HKTDC) in highlighting achievements of 24 tech companies and corporations at the Mobile World Congress (MWC) in Barcelona, marking it the largest delegation to date joining the world's biggest mobile industry event.The Hong Kong Tech Pavilion continues its journey overseas from recent appearance at Consumer Electronics Show (CES) in Las Vegas and engages the premises of Europe, covering the latest solutions in key sectors including Advanced Electronics & Robotics; AI & Data; and Digital Transformation. Ranging from AI-integrated products to automation services, these technological excellence brewed optimism in extending to new frontiers, and gain traction from industry leaders, potential partners, and inspired investors. (Please refer to Appendix 1 for the full list of participants.)A partnership agreement signed between HKSTP and 22@Network Barcelona, and a Memorandum of Understanding signed between HKTDC and Barcelona City Council, both witnessed by Prof Sun Dong, Secretary for Innovation, Technology and Industry Bureau (ITIB) of HKSAR Government, will be urging conversations in promoting collective efforts between the cities for a sustainable I&T future.Albert Wong, CEO of HKSTP, commented: "The world's premier mobile event makes an unrivalledopportunity to forge impactful connections – an important stage for each local tech company to play a role in the European and global markets and accelerate the adoption of transformative solutions. We look forward with excitement to witnessing new opportunities for innovation on both sides emerge at this year's conference."Iris Wong, Director of Merchandise Trade and Innovation & External Relations of HKTDC added: “The HKTDC is committed to showcasing Hong Kong’s dynamic technological prowess on the global stage. We are proud to present 24 outstanding Hong Kong start-ups and tech ventures at the Mobile World Congress, an important global arena showcasing the latest mobile communications advances. Moreover, we are happy to renew our partnership with Barcelona City Council and continuously strengthen cooperation in promoting trade and investment between the two cities. The HKTDC also continues to work closely with the city council to help Hong Kong tech start-ups gain exposure in the Spanish market"As one of the top emerging startup ecosystems, Hong Kong ranks third global after Madrid and Barcelona, and companies from the EU make up the largest foreign business community in Hong Kong, totalling 1,640 according to government data in 2024, and Technology is highly active contributing to this figure, suggesting spotlight in I&T collaborations between the regions is encouraged. Sharing the notion, HKSTP will be joining Hong Kong Economic and Trade Office, London (London ETO), Invest Hong Kong (InvestHK), and the Office for Attracting Strategic Enterprises (OASES) to co-organise a seminar in London, following further on the traction for potential investors, partners, and high-calibre talents to thrive in Hong Kong.Photo 1: Hong Kong Tech Pavilion saw the presence of (from left) Paula Kant, Head of Investment Promotion of InvestHK; Chris Lo, Regional Director, Europe, Central Asia & Israel of HKTDC; Albert Wong, CEO of HKSTP; Susana Prado, President of 22@Network Barcelona; Shirley Yung, Special Represenattive for HK Economic & Trade Affairs to the European Union, Brussels ETO; Prof. Sun Dong, Secretary for Innovation, Technology and Industry of HKSAR Government; Jordi Valls Riera, Deputy Mayor of Barcelona City Council; Iris Wong, Director of Merchandise Trade and Innovation & External Relations of HKTDC; Rocky Cheng, CEO of Cyberport; and Whitney Chan, Senior Systems Manager of Digital Policy Office of HKSAR Government. Photo 2: MoU signed between the HKTDC and Barcelona City Council was represented by Iris Wong, Director of Merchandise Trade and Innovation & External Relations of HKTDC (left) and Jordi Valls Riera, Deputy Mayor of Barcelona City Council (right), and witnessed by Prof. Sun Dong, Secretary for Innovation, Technology and Industry of HKSAR Government (middle). Photo 3: A Partnership agreement signed by Albert Wong, CEO of HKSTP (left in front) and Susana Prado, President of 22@Network Barcelona (right in front) was witnessed by Prof. Sun Dong, Secretary for Innovation, Technology and Industry of HKSAR Government (left in the back) and Jordi Valls Riera, Deputy Mayor of Barcelona City Council (right in the back) in forming an alliance to foster growth of both the I&T communities. Photo 4-5: Derek Chim, Head of Startups Ecosystem and Development of HKSTP (first on the left of Photo 4) joined in sharing Hong Kong’s I&T ecosystem at the 4YFN25, an occasion that connects international innovators, and celebrates achievement and aim to “Create Better.”Photo 6: 24 Hong Kong tech companies and corporations at Mobile World Congress 2025 Barcelona, Spain. Photo 7-10: Showcases of Hong Kong tech companies engaging the local audience.Appendix 1: List of 24 tech companies at the Hong Kong Tech Pavilion including 18 from HKSTP ecosystem (by category):No.CategoryCompany Name1Advanced Electronics & RoboticsAltai Technologies Limited2Arwin Technology Limited3eSIX Limited4Robocore Technology Limited5SMiT Holdings (HK) Limited6Vista Innotech Limited7AI & DataAIqua Corporation Limited8D-Engraver Limited9Palette Space Limited10Solos Technology Limited11Electrical and Mechanical Services Department, HKSAR Government *12Maphive Technology Limited *13MTR Corporation Limited *14Digital TransformationAnimae Technologies Limited15Blue Pin (HK) Limited16Full Nature Farms (Hong Kong) Limited17GoGoChart Technology Limited18Medmind Technology Limited19Meta Mirror Technology Limited *20Pantheon Lab Limited21Preface Technopreneur Limited *22Syngular Technology Limited23Startup EcosystemHong Kong Applied Science and Technology Research Institute Company Limited (ASTRI)24Invest Hong Kong (InvestHK) *Note:- Non-HKSTP park companies marked with (*).About Hong Kong Science and Technology Parks CorporationHong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001 as a thriving I&T ecosystem grooming 14 unicorns, more than 15,000 research professionals and over 2,200 technology companies from 26 countries and regions focused on developing healthtech, AI and robotics, fintech and smart city technologies, etc. The growing ecosystem serves at an international I&T hub in Asia, offers comprehensive support including R&D infrastructure, investment expertise, partnership networks, talent traction and more, in accelerating ideation, and commercialising innovation for technology ventures, all with the I&T journey built around key locations across Hong Kong and branched towards the GBA and further to continuously contribute to the development of I&T making a pillar of growth for Hong Kong. More information about HKSTP is available at www.hkstp.org. About Hong Kong Trade Development CouncilThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels.For more information, please visit: www.hktdc.com/aboutus. Follow us on @hktdc and LinkedIn Media Contact: Hong Kong Science and Technology Parks CorporationSam YanTel: +852 2629 6743Email: sam.yan@hkstp.orgThe Hoffman AgencyDaphne ChanTel: +852 5960 7926Email: dchan@hoffman.comHong Kong Trade Development CouncilKaty WongTel: +852 2584 4524Email: katy.ky.wong@hktdc.comRaconteurBetsy TseTel: +852 9742 7338Email: betsytse@reconteur.hk Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Singapore to Host the 24th Cyber Security Summit: Addressing Emerging Threats and AI-Driven Security ACN Newswire

Singapore to Host the 24th Cyber Security Summit: Addressing Emerging Threats and AI-Driven Security

2025-03-06
SINGAPORE, Mar 5, 2025 - (ACN Newswire via SeaPRwire.com) - As cyber threats continue to evolve, the 24th Cyber Security Summit is set to take place in Singapore, bringing together industry leaders, cybersecurity experts, and technology pioneers to discuss the latest advancements and challenges in digital security. Hosted by Exito Media Concepts Pvt Ltd, the summit will provide key insights into next-generation threat detection, artificial intelligence (AI) in cybersecurity, and cross-border data protection.A Growing Need for Cybersecurity ResilienceA recent cybersecurity incident in Singapore highlights the critical need for proactive security measures. A major financial institution suffered a data breach, exposing sensitive customer information and causing a significant disruption in operations. This attack, attributed to sophisticated ransomware tactics, resulted in a 45% increase in fraudulent transactions and an estimated financial loss of $15 million within a month. Reports indicate that Singapore saw a 32% rise in ransomware incidents in 2023, reinforcing the urgency for advanced cybersecurity frameworks.The 24th Cyber Security Summit, Singapore, aims to address such pressing challenges by facilitating discussions on cutting-edge encryption methods, AI-driven threat detection, and Zero Trust architecture.Keynote and Featured DiscussionsThe summit will kick off with an Opening Keynote on Singapore’s Cybersecurity Strategy, highlighting the country’s commitment to becoming a smart nation with robust digital security infrastructure. Attendees will gain insights into technological innovations such as AI-powered threat detection systems, next-gen encryption methodologies, and proactive incident response frameworks.A panel discussion on AI and cybersecurity, titled The Yin and Yang of AI: Harnessing Power, Mitigating Risk, will explore the dual role of AI in both enhancing and posing risks to cybersecurity. Industry experts will delve into Singapore’s National AI Strategy 2.0, emphasizing ethical AI adoption and cyber resilience.Notable Speakers and Panelists:The event will feature a distinguished lineup of speakers, including:Christophe Barel, Managing Director APAC, FS-ISAC (Moderator)Neal Jetton, Director Cybercrime, INTERPOLJustin Ong, APAC CISO & CPO, Panasonic Asia PacificFrankie Shuai, APAC CISO, DWS GroupJohn Kane, Chief Innovation Officer, Tyme GroupEvent HighlightsThe summit will feature:Fireside Chat: Ransomware Unveiled – Exploring mitigation strategies and incident responses to combat ransomware-as-a-service (RaaS) threats.Spotlight Session: Mastering Data Security – Discussing encryption advancements and AI-driven cybersecurity tools.Roundtable Discussions – Covering key topics such as Zero Trust implementation, cross-border data compliance, and next-gen security tools.Workshops – Hands-on hacking and quantum computing sessions to enhance technical knowledge and defense mechanisms.A Call to Strengthen Cybersecurity PreparednessWith cybercrime damages projected to reach $10.5 trillion annually by 2025, organizations must adopt resilient cybersecurity strategies. The24th Cyber Security Summit serves as a crucial platform for industry leaders to collaborate, share best practices, and explore innovative solutions that safeguard the digital economy.For registration details and more information, visit Cyber Security Summit, Singapore.About ExitoExito, which means success in Spanish, reflects our commitment to the success of our customers. Each year, we organize over 240 virtual and in-person conferences globally, bringing audiences together with world-class thought leaders and C-level executives from various industries. Our carefully curated agendas, based on extensive research and valuable industry insights, facilitate business, knowledge transfer, transaction flow, and impactful messaging for brands.For Media Enquiries, reach out to:Aayesha Zaheer (Sr. Media & PR Executive)aayesha.zaheer@exito-e.com+9174836 58566 Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Doubleview Gold Corp Announces Collaboration with Her Excellency Sheikha Sara Nasser Al-Thani CEO of Qmission W.L.L. Qatar ACN Newswire

Doubleview Gold Corp Announces Collaboration with Her Excellency Sheikha Sara Nasser Al-Thani CEO of Qmission W.L.L. Qatar

2025-03-06
Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - March 5, 2025) - Doubleview Gold Corp. (TSXV: DBG) (OTCQB: DBLVF) (FSE: 1D4) (the "Company" or "Doubleview") is pleased to announce that it has received a Statement of Interest from Her Excellency Sheikha Sara Nasser Al-Thani CEO of Qmission W.L.L. for the Company's Polymetallic HAT Porphyry Deposit, located in northwestern British Columbia, Canada. Her Excellency and Doubleview have entered into an Emissary Agreement to build and foster a potential collaboration with the State of Qatar by way of the Qatar Investment Authority ("QIA") as well as other Arab countries who are seeking to expand business relations, particularly investments in unique and critical mineral deposits that can deliver the resources needed for a sustainable future. Sheikha Sara Nasser Al-Thani is personally involved in seeking business opportunities and building strategic collaborations between different business sectors through her company Qmission that will benefit all parties involved.The Middle Eastern country of Qatar is known for its wealth of natural resources, mainly natural gas (LNG) and oil. In 2005, the Qatar Investment Authority ("QIA") was established. It is the nation's sovereign wealth fund, renowned for its focus on exceptional, one-of-a-kind investments spanning all major global markets, asset classes, sectors and geographies. Her Excellency noted, "This opportunity extends beyond the oil and gas sector and holds significant potential benefits for Qatar. QMISSION's focus is to explore diverse sectors, continuously seeking avenues for growth and innovation. Inspired by the words from the Emir of Qatar, His Royal Highness Sheikh Tamim bin Hamad Al Thani, 'Qatar deserves the best from its citizens,' we remain committed to identifying groundbreaking prospects. Doubleview Gold and its HAT Deposit, with its abundance of copper, gold, cobalt and scandium, represents a golden opportunity in the mining industry."Farshad Shirvani, president & CEO states: "QIA's vision corresponds perfectly with the Hat Project's potential significance on the global stage, due to the deposit's unique variety of critical minerals - copper, cobalt and scandium, in addition to gold and silver - and its size, which sets it apart. This presents a unique investment opportunity. I am honored to have Her Excellency Sheikha Sara Nasser Al Thani as an ally in our mission to develop this deposit and to share my vision with her."The Hat Project features a significant and unique combination of critical metals, including scandium, copper, and gold, among other valuable resources. The Hat Deposit's 2024 maiden resource estimate ("HAT MRE 1.0") reported the following commodities in both indicated and inferred categories, at a cut-off grade of 0.2% copper equivalent ("CuEq"*):Gold: 929k ounces (indicated), 2.328 million ounces (inferred)Copper: 733 million pounds (indicated), 1.945 billion pounds (inferred)Silver: 2.045 million ounces (indicated), 7.575 million ounces (inferred)Cobalt: 28 million pounds (indicated), 91 million pounds (inferred)Scandium: The scandium potential for the Hat Deposit is estimated to be 300 to 500 million tonnes at an average grade of 40 ppm (0.004%) Sc2O3.Note: For further details, please refer to the Company's July 25, 2024, news release.An update to the Company's Maiden Resource Estimate ("HAT MRE 2.0") is expected to be published in Q2, 2025. It will include more than 10,000 meters of additional drill hole information and will be used as part of the Preliminary Economic Assessment ("HAT PEA") concurrently being completed. Updated Scandium metallurgy studies are underway which will be included in the HAT MRE 2.0 and HAT PEA once concluded.* - Copper Equivalent (CuEq) currently does not include the Scandium.- Metal equivalents should not be relied upon for future evaluations.- Parameters used to calculate Copper Equivalent: Au price (US$/oz): 1900; Ag price (US$/oz): 24; Cu price (US$/lb): 4; Co price (US$/lb): 22. Au recovery: 89.0%; Ag recovery: 68.0%; Cu recovery: 84.0%; Co recovery: 78.0%. * Copper Equivalent Calculation CuEq in % = ([Ag grade in ppm] *24*0.68/31.1035 + [Au grade in ppm] *1900*.89/31.1035 + 0.0001* [Co grade in ppm] *22*0.78*22.0462 + 0.0001* [Cu grade in ppm] *4*0.84*22.0462)/(4*22.0462*0.84).Doubleview maintains a website at www.doubleview.ca.Qualified Persons:Erik Ostensoe, P. Geo., a consulting geologist, and Doubleview's Qualified Person with respect to the Hat Project as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects, has reviewed, and approved the technical contents of this news release. He is not independent of Doubleview as he is a shareholder in the company.About Doubleview Gold CorpA mineral resource exploration and development company is headquartered in Vancouver, British Columbia, Canada. It is publicly traded on the TSX-Venture Exchange (TSXV: DBG), (OTCQB: DBLVF), (WKN: LA1W038), and (FSE: 1D4). Doubleview focuses on identifying, acquiring, and financing precious and base metal exploration projects across North America, with a strong emphasis on British Columbia. The company enhances shareholder value through the acquisition and exploration of high-quality gold, copper, cobalt, scandium, and silver projects-collectively critical minerals-utilizing cutting-edge exploration techniques.Doubleview's success is deeply rooted in the unwavering support of its long-term shareholders, supporters, and institutional investors. Their ongoing commitment has been instrumental in advancing the company's strategic initiatives. Doubleview looks forward to further collaborative growth and development, and continues to welcome active participation from its valued stakeholders as the company expands its portfolio and strengthens its position in the critical minerals sector.About the Hat Polymetallic DepositThe Hat Deposit, located in northwestern British Columbia, is a polymetallic porphyry project with major resources of copper, gold, cobalt, and the potential for scandium. As one of the region's significant sources of critical minerals, the Hat deposit has undergone targeted exploration and development. The 0.2% CuEq cut-off resource estimate, as of the recently completed Mineral Resource Estimate and the Company's July 25, 2024, news release, is summarized below: Average GradeMetal ContentOpen Pit Model HatResource CategoryTonnageCuEqCuCoAuAgCuEqCuCoAuAgMt%%%g/tg/tmillion lbmillion lbmillion lbthousand ozthousand ozIn PitIndicated1500.4080.2210.0080.190.421,353733289292,045Inferred4770.3440.1850.0090.150.493,6191,945912,3287,575Scandium potential for the Hat Deposit is estimated to be 300 to 500 million tonnes at an average grade of 40 ppm (0.004%) Sc2O3.For further details, please refer to the Company's July 25, 2024 news release.On behalf of the Board of Directors,Farshad Shirvani, President & Chief Executive OfficerFor further information please contact:Doubleview Gold CorpVancouver, BC Farshad ShirvaniPresident & CEOT: (604) 678-9587E: corporate@doubleview.caNEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.Certain of the statements made and information contained herein may constitute "forward-looking information." In particular references to the private placement and future work programs or expectations on the quality or results of such work programs are subject to risks associated with operations on the property, exploration activity generally, equipment limitations and availability, as well as other risks that we may not be currently aware of. Accordingly, readers are advised not to place undue reliance on forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information, whether as a result of new information, future events or otherwise.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/243263 Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Register Now: analytica Vietnam’s Largest Edition & Must-See Innovations! ACN Newswire

Register Now: analytica Vietnam’s Largest Edition & Must-See Innovations!

2025-03-06
Visitor Registration is Now Open: www.analyticavietnam2025.events-regis.com/Two exhibition halls featuring the latest in laboratory technology, analysis, and biotech solutions.Over 300 exhibitors and brands from across the globe, offering cutting-edge products and innovations.New features like the Start-Up Pavilion, Live Lab Demo, Innovation Zone, and Lab Design & Construction Forum.HO CHI MINH CITY, VIETNAM, Mar 6, 2025 - (ACN Newswire via SeaPRwire.com) - analytica Vietnam 2025, the country’s largest and most influential trade fair for laboratory technology, analysis, and biotechnology, is set to return bigger than ever. Taking place from 2-4 April 2025 at the Saigon Exhibition and Convention Center (SECC), Ho Chi Minh City, this 8th edition will be the largest in the event’s history, expanding to two exhibition halls and welcoming over 300 exhibitors and brands, and 6,000 trade visitors from across the region.Endorsed by the Ministry of Science and Technology in Vietnam and supported by the National Agency for Science and Technology Information (NASATI), Center for Science and Technology Information (CESTI), Key Laboratory of Analytical Technology for Environmental Quality and Food Safety Control (KLATEFOS), VNU, Federal Ministry for Economic Affairs and Climate Action of Germany, and the Association of Small & Medium Enterprises (Singapore), analytica Vietnam 2025 continues to uphold its reputation as a leading industry event.Global Participation and Networking OpportunitiesThis year’s edition will see extensive global participation, with dedicated pavilions from Germany, Singapore, and China, alongside exhibitors from Vietnam, Malaysia, Japan, South Korea, the UK, Switzerland, France, Spain, Turkey, India, and the USA. The event continues to serve as a premier platform for networking, innovation, and business development in the industry. Michael Wilton, Managing Director of MMI Asia, the organizer of analytica Vietnam, expressed, "The continuous growth of analytica Vietnam reflects the increasing demand for advanced laboratory and analytical solutions across Vietnam and the region. Expanding to two halls not only accommodates more exhibitors but also opens up new avenues for collaboration, knowledge exchange, and innovation. We’re excited to welcome professionals from all over the world to experience our largest and most comprehensive edition yet."What to Expect at analytica Vietnam 2025?Academic Conference: Learn from internationally renowned experts as they share research, trends, and findings on topics such as Environmental and Green Chemistry, Food and Quality Control, Pharmaceutical Analysis & Health Science, and Future Technologies.Live Lab Demo: This interactive feature brings advanced analytical instruments, automation, and testing procedures to life, allowing visitors to witness real-time applications across various industries.Innovation Zone: A dedicated area showcasing the newest and most groundbreaking products in laboratory technology, analysis, and biotech solutions.Lab 4.0 Exhibitor Forum: Explore a range of innovative technologies and solutions transforming laboratory operations. Topics will include automation, digitalization, advanced data analytics, new materials, and cutting-edge techniques in laboratory management and research.Lab Design and Construction Forum: Gain insights into the latest trends in lab design, energy-efficient solutions, sustainable practices, and innovative layouts. Industry experts and renowned speakers will share their expertise on creating modern laboratories that meet both functionality and environmental standards.Lucky Draw: Stand a chance to win exciting prizes sponsored by our esteemed exhibitors.Hosted Buyer Program: The largest program yet, with key buyers from Vietnam, Cambodia, Thailand, and Malaysia, invited for exclusive business meetings with exhibitors.Vincent Au Yeong, Country Manager of ITS Vietnam, the event’s Bronze Sponsor, shared, "As a customer of analytica Vietnam for nearly 10 years, I have witnessed the event’s growth and the valuable benefits it brings each year. The continuous development of analytica has reinforced our confidence in its ability to provide insights, foster partnerships, and stay ahead of industry trends. We’re proud to be part of this long-term journey and look forward to further growth together. We can’t wait to meet both our longtime and new customers here."Top 15 Products You Can Look Forward to Seeing at the Exhibition:1. Mixer Mill MM 400 by ITS2. PacBio Revio/Onso Sequencing System by DKSH3. Xevo MRT Mass Spectrometer by Waters4. Liquid Chromatograph Mass Spectrometer by Shimadzu5. epMotion 5075 by Eppendorf6. Biosafety cabinet, Tangerine by Oriental Giken7. High-Speed Amino Acid Analyzer LA8080 by 2H Instrument8. EMC Magnetic Cell Holder by EMCLAB Instruments GmbH9. Hot Head by ELDEX CORPORATION10. Gas generator for TOC Gas Analysis by cmc Instruments GmbH11. Sykam Amino Acid Analyzers by Hoa Viet Co., Ltd12. SCIEX ZenoTOF 7600 SCIEX ZenoTOF 7600 LC-MS/MS System Model: ZenoTOF 7600 by Viet Nguyen Co.,ltd13. Avio 550 ICP-OES - Perkin Elmer14. MIRI® Time-Lapse Incubat or by ESCO15. AI - RIDA®SMART APP Allergen (2024) by R-BiopharmBe Part of analytica Vietnam 2025 – Register Today!To make the most of your experience at analytica Vietnam 2025, we recommend that trade visitors register in advance. This will ensure seamless access to the event and provide updates on the latest developments. For more information and to complete your registration, please visit www.analyticavietnam2025.events-regis.com/About analytica Vietnamanalytica Vietnam is the premier trade fair for laboratory technology, analysis, and biotechnology in Southeast Asia. Organized by Messe München, the event brings together industry professionals, researchers, and policymakers to showcase the latest technologies, exchange knowledge, and foster business collaborations. analytica Vietnam features an exhibition, conference, pre-event laboratory tours, buyer-seller programs, and networking opportunities, providing a comprehensive platform for the laboratory and biotechnology industries in the region. The upcoming edition is set to take place from April 2 to 4, 2025 at the SECC – Saigon Exhibition and Convention Center. More details can be found at https://www.analyticavietnam.com/.About analytica worldwideMesse München is the world’s leading trade fair organizer for laboratory technology, analysis and biotechnology. The international network of exhibitions includes analytica, analytica China, analytica Anacon India & India Lab Expo, analytica Vietnam, analytica USA, and analytica Lab Africa. Additional information about these exhibitions and their programs of events is available at.About MMI Asia Pte LtdEstablished in 1992, MMI Asia is the wholly owned subsidiary and the regional headquarters of Messe München GMBH (MMG) and is one of the world largest and leading exhibition organizers. MMI Asia’s portfolio of events include editions of worldleading trade fairs from Munich – transport logistic & air cargo, analytica, ceramitec; as well as industry-specific events such as Glasstech and Fenestration Asia, Asia Climate Forum, and Singapore International Water Week. MMI Asia also provides consultancy in professional trade fair and conference management to government bodies, international trade and promotion organizations, and trade associations. For more information, please visit www.mmiasia.comAbout Messe MünchenAs one of the world’s leading trade fair organizers, Messe München presents the world of tomorrow at its about 90 trade fairs worldwide. These include twelve of the world’s leading trade fairs such as bauma, BAU, IFAT, electronica, and ISPO. Messe München’s portfolio comprises trade fairs for capital and consumer goods, as well as for new technologies. Together with its subsidiaries, it organizes trade fairs in China, India, Brazil, South Africa, Turkey, Singapore, Vietnam, Hong Kong, Thailand, and the U.S. With a network of more than 15 affiliated companies and almost 70 representations worldwide, Messe München is active in more than 130 countries. The more than 150 events held annually attract around 50,000 exhibitors and around three million visitors in Germany and abroad.Exhibition Contact:MMI Asia Pte. Ltd.Daniel ShiExhibition Directordaniel@mmiasia.com.sgPress Contact:MMI Asia Pte. Ltd.Joey NgMarketing Executivejoey@mmiasia.com.sg Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Historic Global Anti-Scam Summit Convenes in London to Combat Escalating Online Fraud ACN Newswire

Historic Global Anti-Scam Summit Convenes in London to Combat Escalating Online Fraud

2025-03-06
LONDON, Mar 4, 2025 - (ACN Newswire via SeaPRwire.com) - In a landmark event, the United Kingdom will host the Global Anti-Scam Summit (GASS) London 2025, bringing together an unprecedented number of policymakers, industry leaders, and cybersecurity experts. This summit, organized by the UK Home Office, Global Anti-Scam Alliance (GASA), Cifas, and Euroconsumers, is set to be the most significant anti-scam event to date, with a focus on forging global partnerships to address the rampant rise of online scams, which last year cost the global economy nearly US$1.03 trillion.Unveiling Global Strategies Against ScamsThe summit will kick off with keynote speeches from top international figures, including The Rt Hon Lord Hanson of Flint, who will outline the UK's initiatives and the collaborative efforts needed to combat this global menace. Discussions will focus on enhancing international cooperation, harmonizing scam prevention efforts, and leveraging technology to protect consumers worldwide.Panel discussions on the first day will explore the urgent need for coordinated global action. Sessions will dive into the human cost of scams, share international lessons in scam prevention, and highlight the role of public-private partnerships in advancing fraud legislation and industry best practices. The main focus of the event is to foster cross-border and -sector collaborations.Industry Leaders to Drive Technological InnovationsThe summit will also feature contributions from tech giants and financial institutions, focusing on how cutting-edge technologies like AI can be utilized to thwart scammers effectively. Industry leaders will discuss the creation of the Global Signal Exchange, an innovative platform aimed at enhancing data sharing across borders to better track and prevent scams.Day two of GASS London 2025 will be dedicated to solutions-focused workshops and breakout sessions. Experts will present the latest advancements in scam detection and prevention, from deepfake recognition to strategies for securing digital identities. Interactive discussions will enable participants to share insights and develop actionable strategies for protecting consumers globally, such as the GASA recommendation that every country should have a dedicated national anti-scam centre.The event agenda and attendance tickets are available here: https://www.gasa.org/gass-2025-londonThe summit will look to solidify commitments from attending public and private organizations and set a roadmap for international cooperation through 2026 and beyond.GASS London 2025 is a call to action for every stakeholder in the fight against online fraud. It offers a unique opportunity to join forces with global leaders and take a stand against the cyber threats that impact millions of lives each year.Selected speakers include:Aad Lensen, Jeroen Niessen, and Ruben van Well, Dutch PoliceAndrei Skorobogatov, Home OfficeAngelique Miet, European CommissionBen Donaldson, UK FinanceDr Elizabeth Carter, Kingston University LondonEls Bruggeman, EuroconsumersHedwige Nuyens, International Banking Federation (IBFed)Henriette Bongers, FraudeHelpdesk.nlJayde Richmond, Australian National Anti-Scam CentreJean-Jacques Sahel, GoogleJorij Abraham, GASAKate Griffin, Aspen InstituteKitboga, YouTube ScambaiterLaura Kankaala, F-SecureLucia Harris, Match GroupLuke Reynolds, MastercardLynette Owens, Trend MicroMike Haley, CifasNatalie Black, OFCOMNathaniel Gleicher, MetaThe event agenda and attendance tickets are available here: https://www.gasa.org/gass-2025-londonContact InformationSam RogersMarketing Director, Global Anti-Scam Alliancesam.rogers@gasa.org+31 (0) 645 130 670Hayley PatersonPress & PR Manager, Cifashayley.paterson@cifas.org.ukRelated VideoSOURCE: Global Anti-Scam AllianceRelated Documents: Global State of Scams Report - 2024.pdfState of Scams in the United Kingdom Report - 2024.pdf Copyright 2025 ACN Newswire via SeaPRwire.com.
More
General Atomics Acquires North Point Defense ACN Newswire

General Atomics Acquires North Point Defense

2025-03-06
SAN DIEGO, CA, Mar 3, 2025 - (ACN Newswire via SeaPRwire.com) - General Atomics (GA) today announced the strategic acquisition of North Point Defense, Inc. (NPD), a leading provider of Signals Intelligence (SIGINT) exploitation software and sensor integration, by General Atomics Integrated Intelligence, Inc. (GA-III), formerly known as General Atomics Commonwealth Computer Research, Inc. This acquisition enhances GA's capabilities in the rapidly evolving SIGINT field, positioning the company to deliver advanced ISR solutions for air, sea, ground, and space platforms.The new Quadratix enterprise will bond GA's large software workforce and extensive suite of systems under a unified umbrella, merging solutions for: From concept to deployment, NPD delivers AI/ML-based autonomous signal processing and data dissemination solutions providing real-time actionable intelligence, supporting tactical and national mission priorities. "Joining GA represents an incredible opportunity to enhance our impact in delivering cutting-edge SIGINT solutions in support of national and tactical users," said Bruce Benenati, President of NPD. "As part of a mission-focused organization with a proven track-record in tactical intelligence across the DoD and IC, we can accelerate innovation and deployment at scale. The integration gives our team access to unmatched operational expertise, resources, and a broader customer base. Together, we are poised to deliver even greater capabilities to those who depend on us in the field."GA-III is committed to providing a comprehensive suite of "out-of-the-box" hardware and software tools to meet mission requirements and expand the innovative intelligence capabilities within the GA group of companies. "The integration of NPD technologies into a division of GA-III is a strategic shift, enhancing GA's ability to innovate rapidly and provide greater value to customers with end-to-end ISR solutions that are more efficient, effective, and technologically advanced." said Brian Ralston, President of GA-III.Baird served as the exclusive financial adviser and Miles & Stockbridge acted as legal counsel to North Point Defense on the transaction.About General Atomics and General Atomics Integrated IntelligenceGeneral Atomics is a defense and diversified technologies company, founded in 1955 as a division of General Dynamics and acquired by the Blue family in 1986. GA and affiliates operate on five continents, and produce unmanned aircraft and airborne sensor systems, satellite surveillance, high power laser, hypervelocity projectile, and power conversion systems. GA is a leader in nuclear fusion research, next-generation nuclear fission and advanced materials technologies. The company occupies 8+ million square feet of engineering, laboratory and manufacturing facilities and comprises over 13,000 employees.GA-III's capabilities include spatio-temporal data management, advanced analytics, visualization tools, and computer vision, alongside AI/ML-enabled automated target recognition services. These capabilities support a wide range of national, tactical, and commercial/international applications, leveraging both commercial cloud and edge-based computing solutions and are fully integrated with GA Aeronautical Systems' unmanned aircraft and airborne sensor systems.Media Contact: https://www.ga.com/general-business-inquiriesContact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.comSOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
CTF Life is the Sole Diamond Sponsor of Kai Tak Sports Park Grand Opening Ceremony ACN Newswire

CTF Life is the Sole Diamond Sponsor of Kai Tak Sports Park Grand Opening Ceremony

2025-03-06
HONG KONG, Mar 4, 2025 - (ACN Newswire via SeaPRwire.com) – CTF Life proudly announces to be the sole Diamond Sponsor of the highly anticipated Kai Tak Sports Park (KTSP) Grand Opening Ceremony, cementing its appointment as the exclusive Founding Insurance Partner of KTSP. CTF Life celebrated this historic moment at the main stadium alongside its customers, Life Planners, partners, staff and their families. The deepened partnership with KTSP underscores the company’s robust financial strengths and commitment to supporting the Hong Kong SAR Government in promoting local culture, sports, and tourism, creating value beyond sportsmanship.Man Kit IP, Executive Director and Chief Executive Officer of CTF Life, said: “As the exclusive Founding Insurance Partner of KTSP and the proud Diamond Sponsor of its opening ceremony, we are truly making history with this significant milestone for both Hong Kong and CTF Life. Our collaboration with KTSP across multiple areas empowers local athletes and performers to unlock their full potential at Hong Kong’s largest integrated sports and entertainment landmark. The partnership will not only bring in world-class international events but also champion the ‘Sports for All’ culture, thus delivering exceptional and diverse experiences for our customers, fulfilling our promise to create value beyond insurance.” Ellick Tsui, Executive Director and Deputy Chief Executive Officer of CTFLife (second from the right), together with the company’s management, celebrates the historic moment at CTF Life’s suite at KTSP. CTF Life’s brand presence across the main stadium during the ceremony.At the opening ceremony, CTF Life’s brand was prominently displayed in the main stadium, making a strong impression on the live audience, TV viewers and across various platforms. The company had earlier announced its title sponsorship of the “Fencing Plus” Training Programme by Kai Tak Sports Initiative, aimed at nurturing a new generation of elite fencing athletes representing Hong Kong and helping them unleash their potential to become world champions. Registration will open later this month, and parents can enrol their children by joining the CTF Life • CIRCLE membership programme.About CTF LifeChow Tai Fook Life Insurance Company Limited (“CTF Life”) is proud of its rich, 40-year legacy in Hong Kong. CTF Life is a wholly-owned subsidiary of CTF Services Limited (Hong Kong Stock Code: 659) and one of the most well-established life insurance companies in Hong Kong. As a member of Chow Tai Fook Enterprises Limited, CTF Life consistently strengthens its collaboration with the diverse conglomerate of the Cheng family (“Chow Tai Fook Group” or “the Group”) to support customers and their loved ones in navigating life’s journey with personalised planning solutions, lifelong protection and diverse lifestyle experiences. By leveraging the Group’s robust financial strength and strategic investments across the globe, CTF Life aspires to become a leading insurance company in Asia while continuously creating value beyond insurance.Media enquiriesCTF LifeZoey Lau+852 2591 8314zoey.lau@ctflife.com.hk Chow Tai Fook Life Insurance Company Limited (Incorporated in Bermuda with limited liability) Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Hong Kong International Jewellery Show opens today showcasing global innovative designs ACN Newswire

Hong Kong International Jewellery Show opens today showcasing global innovative designs

2025-03-05
- The Hong Kong International Jewellery Show launches today (4 March) and runs until 8 March, showcasing a wide range of designs incorporating creative and cultural elements- The debut “Young Jewellery Designer Arena” showcases the creativity and craftsmanship of up-and-coming talents- The results of two major jewellery design competitions are revealed today. The International Jewellery Design Excellence Award features 80 worldwide award-winning pieces competing for the "Champion of the Champions". The design that clinched both the Best of Show Award in the Open Group and the Craftsmanship & Technology Award in the Hong Kong Jewellery Design Competition was a beautifully crafted ring inspired by Monet's "Water Lilies"HONG KONG, Mar 4, 2025 - (ACN Newswire via SeaPRwire.com) - The 41st Hong Kong International Jewellery Show, organised by the Hong Kong Trade Development Council (HKTDC), opens today at the Hong Kong Convention and Exhibition Centre (HKCEC) and runs for five consecutive days, closing on 8 March. It runs concurrently with the 11th Hong Kong International Diamond, Gem & Pearl Show which opened on Sunday (2 March) at AsiaWorld-Expo and finishes on 6 March. This year's twin jewellery shows have attracted some 4,000 exhibitors from more than 40 countries and regions, showcasing a spectrum of jewellery raw materials, finished products and technological tools, helping to create an international one-stop jewellery trading platform.Leading the trend with innovative and fashionable designsThe jewellery industry is increasingly focusing on fashionable styles, with innovative designs becoming key to helping products stand out in the market. For many years, the Hong Kong International Jewellery Show has provided an excellent platform for exhibitors to showcase their boundless creativity and exquisite craftsmanship. This year, Hong Kong exhibitor OSI Vitoria Jewelry (Booth: CEC GH-E08) introduces a floral necklace featuring a 62-carat emerald surrounded by more than 3,400 spinels, sapphires and diamonds, depicting the dazzling moment of fireworks lighting up the sky. Japanese exhibitor Jewelry of Raden & Urushi (Booth: CEC 1CON-016) presents a dragon-shaped brooch and pendant made of 18K gold, Akoya pearls, diamonds and mother-of-pearl, with intricate craftsmanship that imbues the design with life. Australian exhibitor Autore Pearls Pty Ltd (Booth: CEC GH-C32) showcases a vivid snake-shaped necklace that echoes the Year of the Snake, adorned with pearls, diamonds and gemstones. In the newly added Gold Jewellery Zone, Malaysian exhibitor Chl Innovation Industries Sdn Bhd (Booth: CEC 3E-D15) exhibits a durian pendant with distinctive local charm.Many exhibitors keep their fingers on the pulse of jewellery trends and launch creative products incorporated with traditional cultural elements. Hong Kong exhibitor Zuri Jewelry Company Limited (Booth: CEC 1E-C18) capitalised on Hong Kong’s “panda economy” to introduce its "Panda and Bamboo" jewellery collection. Changzhou Yi'an Jewelry Co., Ltd (Booth: CEC 1CON-029) from Mainland China harnesses filigree inlay technique, an almost-lost craft that is part of China’s intangible cultural heritage, to create 18K gold wheatears – a piece that won the Best Design Award in the 2019 Tiangong Awards.A new addition to this year’s show is the Young Jewellery Designer Arena, showcasing the creations and craftsmanship of up-and-coming talents to global buyers. The event also features 18 national, regional and industry pavilions, including the UK Pavilion led by British Jewellery & Giftware International with sophisticated jewellery pieces from eight British designers.Two major jewellery design competitions discover and nurture new talentsThe HKTDC has always put great emphasis on discovering and nurturing emerging talents to further elevate the standard of jewellery design. This year, it has once again joined hands with The Jewellers’ & Goldsmiths’ Association of Hong Kong Limited, Hong Kong Jewellery & Jade Manufacturers Association, Hong Kong Jewelry Manufacturers' Association and the Diamond Federation of Hong Kong, China Ltd to organise the 7th International Jewellery Design Excellence (IJDE) Award and the 26th Hong Kong Jewellery Design Competition (HKJDC) to identify new talents. The award ceremonies for the two competitions were held this morning and the winning entries will be on display at the Hall 1D and 1E Concourse throughout the International Jewellery Show. Held for the first time since the pandemic, the 2025 IJDE Award received an enthusiastic response with 80 award-winning entries from nine countries and regions competing for the highest honour – the “Champion of the Champions”. The entries were assessed by an esteemed panel of judges with Lawrence Ma, Chairman of the HKTDC Hong Kong International Jewellery Show and HKTDC Hong Kong International Diamond, Gem & Pearl Show Fair Organising Committee, serving as chief judge and other members including representatives from L’ECOLE, School of Jewelry and the De Beers Group, among others. (See Table 1 for the list of selected winning entries from the 7th IJDE Award.)The theme for this year's HKJDC was "Lasting Brilliance", encouraging participants to showcase the enduring allure of jewellery through their creations. The competition was divided into an Open Group and Student Group and received a total of 86 entries. The judging panel, made up of six professionals from diverse fields such as jewellery and design, selected the winning entries after careful consideration. (See Table 2 for the list of selected winning entries from the 26th HKJDC.)Series of events enhance industry networkingA jewellery networking reception is being held tonight to boost connections among participants, welcoming jewellery industry representatives and both local and international buyers. Salina Yan, Permanent Secretary for Financial Services and the Treasury (Financial Services) of the Hong Kong SAR Government, will be the Guest of Honour. In addition, three jewellery parades will be held during the show, echoing its "Symphony of Sparkles" theme with displays of exquisite jewellery pieces. Over the course of the twin jewellery shows, more than 30 industry seminars, parades and other activities are being organised to further facilitate industry exchange.Table 1: Selected winning entries from the 7th International Jewellery Design Excellence AwardChampion of the ChampionsTitle of winning design: The KaleidoscopeDesigner: Nadia Neuman （Australia）Category: NecklaceDescription*:Designed with interchangeable components, this can be worn in a number of ways and features a fully functioning kaleidoscope. It showcases the beauty and versatility of natural coloured diamonds in both polished and rough formsInnovative and Uniqueness in Design AwardTitle of winning design: Summer Night CelebrationDesigner: Ying Chen CHEN （Taiwan）Category: EarringsDescription*:The inspiration for this piece comes from the mystical Barringtonia flower – a night fairy of the summer. Her life lasts only for a single nightAs dusk falls, she blooms in quiet elegance, only to gently descend with the first light of dawn. Though her existence is fleeting, she shines like fireworks and is breathtakingly beautifulIn this design, I sought to capture the moment when the stamens burst forth from the bud, with countless filaments unfurling like delicate tendrils, radiating boundless energy, vitality and freedom. This imagery deeply moved me, reminding me that “Life, like a flower, is fleeting – not measured by its length, but by whether it has burned brightly”As a jewellery designer, I often ask myself: what can I leave behind in this world' Perhaps, through my creations, I can transform those fleeting moments of emotion into eternal beautyCraftsmanship AwardTitle of winning design: Born of BlueDesigner: CHAN Hoi Yi （Hong Kong）Category: Pendant/BroochDescription*:Inspired by a proverb from my favorite philosopher Xunzi: "Born of blue, but better than blue"Blue dye was distilled from the indigo plant, but the dye was bluer than the plant itself. The knowledge taught by teacher made the students surpass the teacher himselfThis inspired my design like a visual metaphor: the Chinese-Cloud symbolises knowledge (an everchanging form/law of nature)ï¼›Chinese-Knots symbolise teacher/students (from a simple to a complex shape, to the deepening of blue colours. The progress symbolises self-improvement)I admire the vague elegance in this proverb. It's humble, pure, not flashy, with a scent of scholarly temperament, with goodwill and charm. It may sound a bit naive and idealistic today, but that’s what I want to express in this jewelleryAesthetics AwardTitle of winning design: ContemplationDesigner: Mariia EFIMOVA （Russia）Category: RingDescription*:In a world where everything happens too fast, beauty is commonplace, and we are often seduced only by the outside. But the underside sometimes says much more. "Contemplation" is an invitation to stop and a reminder that true beauty lies within us Table 2: Selected winning entries from the 26th Hong Kong Jewellery Design CompetitionOpen Group – Best of Show Award and Craftsmanship & Technology AwardTitle of design: Romance & ClassicsDesigner: Tse Ka-wingCategory: RingDescription*:Jewellery and renowned artworks share an inseparable relationship and common origins. The designer drew inspiration from elements of Impressionist painter Claude Monet's "Water Lilies", using jewellery to showcase the romance and elegance of classic paintingsOpen Group – Best of Show AwardTitle of design: Victoria • ButterflyDesigner: Chan Wing-longCategory: RingDescription*:Against the backdrop of Victoria Harbour, a giant butterfly flies high in the air, blending colour and shadows. The butterfly is like a dream, conveying people's longing and desire for the future. Each flap of the butterfly’s wings is a hymn to lifeOpen Group – Best of Show AwardTitle of design: WHIMSYDesigner: Chow Tin-yiCategory: Pendant/BroochDescription*:The hourglass cradles the gentle dreams of childhood, each glowing grain of sand falls softly to capture the delicate passage of time and its precious moments. A pendant, delicate and detachable, imbues the piece with elegance and personality, speaking of eternity and the sparkle of dreamsStudent Group – ChampionTitle of design: Blossom in PorcelainDesigner: Liu KanglanSchool: The Hong Kong Polytechnic UniversityCategory: RingDescription*:The blue and white porcelain is a manifestation not only of beauty, but also the passing of time and the continuity of Chinese culture. Incorporating a blue and white contrast and complex patterns into the design reflects the enduring appeal of traditional Chinese porcelain – a quality that shines stillStudent Group – 1st Runner-upTitle of design: Divine WhispersDesigner: Mak Wing-muiSchool: Saint Francis UniversityCategory: EarringsDescription*:The earrings draw inspiration from the sanctity of cathedrals, featuring geometric lines that outline the elegant silhouette of spires and domes. The cross atop symbolises eternal blessings and protection, while the central purple gemstone resembles heavenly light shining down. Adorned with vibrant enamel, the earrings reflect the dazzling brilliance of stained glass under sunlightStudent Group – 2nd Runner-upTitle of design: OliviaDesigner: Lau Cheuk-laiSchool: HKCT Institute of Higher EducationCategory: Bracelet/NecklaceDescription*:Olivia, a name inspired by the enduring legacy of the olive, embodies timeless elegance. The necklace, meticulously handcrafted with bold but lightweight meshed, hollowed constructions, features a 4-carat cushion-cut ruby that, like the olive, symbolises longevity and resilienceBeyond its luxurious appeal, Olivia represents family heritage and timelessness, akin to the olive tree’s historical significance, with over 6,000 years of cultural influence in the Mediterranean. Capturing enduring brilliance and embodying timeless virtues and beliefs, makes this a legacy piece for generations *The designers provided the description for their award-winning workFull list of the winning entries from the 7th International Jewellery Design Excellence Award: https://hkjewellery.hktdc.com/pdf/2025/IJDEA2025.pdfFull list of the winning entries from the 26th Hong Kong Jewellery Design Competition: https://www.hktdc.com/event/hkjewellery/en/the-26th-hong-kong-jewellery-design-competition-result-announcementThe 41st Hong Kong International Jewellery Show, organised by the HKTDC, commenced today at the Hong Kong Convention and Exhibition Centre, running in parallel with the 11th Hong Kong International Diamond, Gem & Pearl Show at AsiaWorld-Expo. The twin shows have attracted the participation of some 4,000 exhibitors from more than 40 countries and regionsHong Kong exhibitor OSI Vitoria Jewelry (Booth: CEC GH-E08) in the Hall of Extraordinary introduces a floral necklace featuring a 62-carat emerald surrounded by more than 3,400 gems and diamonds, depicting the dazzling moment of fireworks lighting up the skyIn the Designer Jewellery Galleria, Japanese exhibitor Jewelry of Raden & Urushi (Booth: CEC 1CON-016) presents a dragon-shaped brooch and pendant made of 18K gold, Akoya pearls, diamonds and mother-of-pearlAustralian exhibitor Autore Pearls Pty Ltd (Booth: CEC GH-C32) showcases a snake-shaped necklace that echoes the Year of the Snake, adorned with pearls, diamonds, and gemstonesThe Young Jewellery Designer Arena debuts at this year's International Jewellery Show, showcasing the creations and craftsmanship of up-and-coming designers to global buyersWinners of the 7th International Jewellery Design Excellence Award pictured at the award ceremony with distinguished guestsWinners of the 26th Hong Kong Jewellery Design Competition pictured at the award ceremony with distinguished guestsPhoto download: https://bit.ly/3QI66F3Fair detailsHong Kong International Jewellery ShowDateOpening hours4 March 2025 (Tuesday)10:30am-6:30pm5-7 March 2025 (Wednesday to Friday)10am-6:30pm8 March 2025 (Saturday)10am-5:30pmVenueHong Kong Convention and Exhibition Centre, 1 Expo Drive, Wan ChaiPress Registration & Media CentreMedia representatives can register at the entrance of HKCEC Hall 1D Concourse, or at the HKTDC Media Centre (G/F, Expo Drive Entrance, HKCEC) by presenting a business card or media identification.Hong Kong International Diamond, Gem & Pearl ShowDateOpening hours2 March 2025 (Sunday)10:30am-6:30pm3 -5 March 2025 (Monday to Wednesday)10am-6:30pm6 March 2025 (Thursday)10am-5:30pmVenueAsiaWorld-Expo, Hong Kong International Airport, Lantau, Hong KongPress registration and Media CentreMedia representatives can register at the entrance of AsiaWorld-Expo’s East Lobby (Opposite Hall 3 next to the escalator), or at the Media Centre (Room 201C, 2/F) by presenting a business card or media identification. ****For security reasons, all media will be required to present a name card and valid photo-bearing identity card (or passport) for press registration. Individuals with a valid press pass will be required to present their identity card (or passport) again at the entrance to the exhibition halls. Please allow sufficient time for registration.Websites Hong Kong International Jewellery ShowHong Kong International Diamond, Gem& Pearl ShowWebsitehttps://www.hktdc.com/event/hkjewellery/enhttps://www.hktdc.com/event/hkdgp/enSelected productshttps://bit.ly/4hE1ifzShuttle bus arrangementhttps://www.hktdc.com/event/hkjewellery/en/travel-to-fairground-hkcechttps://www.hktdc.com/event/hkdgp/en/travel-to-fairground-aweActivity listhttps://www.hktdc.com/event/hkjewellery/en/intelligence-hubhttps://www.hktdc.com/event/hkdgp/en/intelligence-hubHKTDC Media Room: https://mediaroom.hktdc.com/enMedia enquiriesPlease contact HKTDC’s Communication & Public Affairs Department:Sharon HaTel: (852) 2584 4575Email: sharon.mt.ha@hktdc.orgSerena CheungTel: (852) 2584 4272Email: serena.hm.cheung@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lawuw@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Nissin Foods (Hong Kong) Charity Fund Supporting Talents in Food and Nutritional Sciences for the Third Consecutive Year ACN Newswire

Nissin Foods (Hong Kong) Charity Fund Supporting Talents in Food and Nutritional Sciences for the Third Consecutive Year

2025-03-05
HONG KONG, Mar 3, 2025 - (ACN Newswire via SeaPRwire.com) - Nissin Foods (Hong Kong) Charity Fund (“Charity Fund”) announced its continued support for outstanding food and nutritional sciences students from The Chinese University of Hong Kong (“CUHK”) for the third consecutive year. The 2024-2025 Nissin Foods Scholarship Presentation Ceremony was held today to present scholarships to 13 undergraduate and postgraduate students, who strive for excellence in their academic performance and aspire to become future industry leaders.Established by the Charity Fund and CUHK in 2022, the scholarship will cover their full tuition fees for the academic year, and is renewable, subject to annual performance review, with the intent to support the students throughout their study period, so that they can focus on their studies without worrying about financial burdens. The four new awardees for the 2024-2025 academic year are: LEUNG Hau Man, LO Chun Hei and WONG Siu Yu from CUHK’s Bachelor of Science in Food and Nutritional Sciences programme, and ZHOU Zhengming from the PhD programme. The nine renewed awardees are LAM Tsz Hang, SHUM Wai Hang, CHAN Hoi Yi, HSU Po Ling, KWAN Ka Yi, LAM Shuk Fan and WONG Wai Yee from the Bachelor’s degree programme, and ZHOU Dandan, LIN Yuhong from the PhD programme. Mr. Kiyotaka ANDO, Chairman of Nissin Foods (Hong Kong) Charity Fund, said, "At Nissin Foods, we believe that food-related jobs are sacred professions. They serve both life and society. We share the values with The Chinese University of Hong Kong in nurturing outstanding and caring food professionals, who will contribute to Hong Kong's development. By empowering students studying food and nutritional sciences in CUHK and elite athletes aspiring to become teachers from the Education University of Hong Kong, we promote a healthy lifestyle through food and sports. This reflects the vision of our founder, Mr. Momofuku Ando, who said, ‘Eating and sports are the two axles of health."Professor Anthony CHAN, Pro-Vice-Chancellor and Vice-President of The Chinese University of Hong Kong, expressed his genuine gratitude for the generous support of the Charity Fund to CUHK, said, "Mr. Momofuku Ando, the Founder of Nissin Foods, was a visionary leader who dedicated himself to serve our society through technological innovation and had the courage to create positive change in our lives. His spirit continues to inspire many of us. CUHK has all along been committed to providing fertile ground for nurturing the future leaders of our society. We feel privileged that our vision in advancing higher education has been shared by Nissin Foods."Ms. WONG Wai Yee, on behalf of all the scholarship recipients, thanked the Charity Fund and CUHK for setting up the scholarship scheme and presented a booklet of appreciation from the 13 awardees to Mr. Kiyotaka ANDO. She said, "This scholarship empowers us to pursue our passions and aspirations in the realm of food and nutrition without constraints. As Nissin Foods Scholars, we are driven by a spirit of innovation to contribute to solutions for a secure and healthy global food supply, ensuring that the benefits of food and nutrition reach every corner of the world."PhotoMr. Kiyotaka ANDO, Chairman of Nissin Foods (Hong Kong) Charity Fund (middle right), and Professor Anthony CHAN, Pro-Vice-Chancellor and Vice-President of CUHK (middle left), attended the 2024-2025 Nissin Foods Scholarship Presentation Ceremony today. There are 13 scholarship recipients for the 2024-2025 academic year. The four new awardees this year are (front, from left to right) LEUNG Hau Man, LO Chun Hei and WONG Siu Yu from CUHK’s Bachelor of Science in Food and Nutritional Sciences programme, and ZHOU Zhengming from the PhD programme. The nine renewed awardees are: (back, from left to right) LAM Tsz Hang, SHUM Wai Hang, ZHOU Dandan, CHAN Hoi Yi, HSU Po Ling, KWAN Ka Yi, LAM Shuk Fan and WONG Wai Yee, and LIN Yuhong from the Bachelor’s degree or the PhD programme.About Nissin Foods (Hong Kong) Charity FundThe Nissin Foods (Hong Kong) Charity Fund (“Charity Fund”) was set up in September 2020 by way of a trust deed by Nissin Foods Company Limited (Stock code: 1475). The objectives of the Charity Fund are: a) to advance education, teaching, learning, arts, science and academic research; b) to make provision for people in need; and c) to carry out works of a charitable nature that are beneficial to the Hong Kong community. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Hua Medicine Awarded Shanghai Innovative Enterprise Headquarters ACN Newswire

Hua Medicine Awarded Shanghai Innovative Enterprise Headquarters

2025-03-05
SHANGHAI, Mar 3, 2025 - (ACN Newswire via SeaPRwire.com) - On February 27th, the awarding ceremony of the second batch of Shanghai Innovative Enterprise Headquarters was held in Shanghai. Gong Zheng, Deputy Secretary of Shanghai Municipal Party Committee and Mayor of Shanghai, awarded the certificates to 49 innovative enterprise headquarters, and Hua Medicine was among them. Dr. Li Chen, the founder and CEO of the Company, went on stage to receive the award and delivered a speech as a representative of the enterprises.(Gong Zheng, Deputy Secretary of Shanghai Municipal Party Committee andMayor of Shanghai, awarded the titles to innovative enterprise headquarters)Innovative enterprises are an important part of Shanghai's modern industrial system and the source of vitality for Shanghai's high-quality development. In recent years, innovative enterprises in Shanghai have been growing and developing rapidly, having an obvious driving effect on the industry. The enterprises awarded this time are from key industrial fields such as integrated circuits, biomedicine, artificial intelligence, digital economy, and emerging strategic comprehensive industries. All the selected enterprises exhibit the characteristics of strong innovation leadership, vigorous development vitality, and obvious agglomeration development. (Certificate of innovative enterprise headquarters)Hua Medicine, headquartered in Shanghai but with a global outlook, is leveraging China's evolving pharmaceutical regulatory landscape and the innovative drug full-chain industrial environment such as the pharmaceutical research and development, production, and business environment created by Shanghai to continuously accelerate the transformation and implementation of innovative achievements. Hua Medicine took ten years to develop a globally first-in-class and national Class I new drug, glucokinase activator (GKA) dorzagliatin (Trade name:) independently, which was first launched in China, with a globally new target and a new mechanism.In September 2022, dorzagliatin was approved for marketing by the National Medical Products Administration of China for the treatment of type 2 diabetes. It is the first GKA approved for marketing worldwide and has also become the tenth class of diabetes treatment drugs recognized by the World Health Organization (WHO). By the end of 2023, dorzagliatin was successfully included in China's National Reimbursement Drug List (NRDL), greatly improving the accessibility and affordability of this innovative drug for patients.As a global innovation leader in the GKA field, Hua Medicine has received national-level awards on multiple occasions during the research and development period and after the product launch, and has undertaken major national projects. These include being consecutively selected as a major new drug development special project under the "12th Five-Year Plan" and the "13th Five-Year Plan” by the Ministry of Science and Technology, and winning the First Prize of the Science and Technology Award of the Chinese Pharmaceutical Association, among others. Currently, Hua Medicine is actively carrying out the development of the second-generation GKA and fixed combination preparations, aiming to bring more innovative and good drugs to patients in China and even globally in the fields of diabetes and its complications, such as obesity and diabetic nephropathy. (Dr. Li Chen delivered a speech as a representative of the enterprises)As a representative of the enterprises, Dr. Li Chen said in his speech at the awarding ceremony: "Coinciding with the new era and new journey of Shanghai accelerating the construction of a scientific and technological innovation center and fully promoting the upgrading and development of strategic emerging industries, Hua Medicine being recognized as the Shanghai Innovative Enterprise Headquarters is an affirmation of the enterprise's past and also an encouragement and inspiration for the enterprise's future development. Hua Medicine will continue to leverage its advantages of conceptual innovation, technological innovation, and model innovation, keep making progress, and contribute to the construction of Shanghai's scientific and technological innovation center and the innovative development of the biomedicine industry."Receiving the title of "Shanghai Innovative Enterprise Headquarters" this time is not only an honor for Hua Medicine but also a responsibility and mission. In the future, taking this as an opportunity, Hua Medicine will continuously increase its innovation investment and the ability of achievement transformation, continuously enhance its international competitiveness, provide more high-quality innovative drugs and treatment solutions for patients, help Shanghai's biomedicine industry reach new heights, and promote the construction of the "Healthy China" strategy.About Hua MedicineHua Medicine (The “Company”) is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin for adult T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with renal function impairment.For more informationHua MedicineWebsite: www.huamedicine.comInvestorsE-mail: ir@huamedicine.comMediaEmail: pr@huamedicine.com Copyright 2025 ACN Newswire via SeaPRwire.com.
More
General Atomics Introduces Quadratix Software Enterprise ACN Newswire

General Atomics Introduces Quadratix Software Enterprise

2025-03-05
SAN DIEGO, CA, Mar 3, 2025 - (ACN Newswire via SeaPRwire.com) - General Atomics is reshaping its software enterprise for the future, merging efforts from across business lines into a single technology grid delivering all-domain response and information dominance.The new Quadratix enterprise will bond GA's large software workforce and extensive suite of systems under a unified umbrella, merging solutions for:Autonomy, artificial intelligence and machine learningAirborne intelligence, surveillance, and reconnaissanceLand-based advanced sensingSea-based threat detectionSpace-based missions and satellite operationsCyber exploitationUnified data fusion and visualizationThis new cross-functional collaboration is designed to promote interoperability across all GA product lines, providing streamlined options for customers hoping to capitalize on the breadth and depth of General Atomics' expertise.As one of the largest privately held defense companies in the world, General Atomics has been a disruptive force in aerospace and defense technology for decades, employing more than 1,000 software engineers, programmers and related experts. Our new Quadratix enterprise merges software efforts from across the company's various affiliate divisions, including Aeronautical Systems, Inc. (GA-ASI); Electromagnetic Systems Group (GA-EMS); Integrated Intelligence, Inc. (GA-III); and other General Atomics holdings.The move offers new options for both current and future GA customers. One example is the unmanned aircraft delivered by GA-ASI, with its industry-leading Predator® series of UAS and future-forward autonomous jets, which will benefit from increased collaboration on autonomy, AI and ML produced by other GA divisions."We've transcended a one-for-one software build and arrived at an integrated suite of software solutions for our aircraft and our customers," said GA-ASI CEO Linden Blue. "We're moving out fast to meet our users' toughest challenges by grouping these solutions together under the Quadratix umbrella."GA's transformational technologies continue to revolutionize how global military forces address complex challenges and respond to evolving threats. From data processing, exploitation, and dissemination to data fusion and real-time situational awareness, our vertically integrated software teams work closely with our hardware engineers to build versatile, flexible systems that mesh seamlessly behind the scenes."Quadratix integrates across our full catalog of subordinate systems to command, control, collect, catalog, and communicate information and intelligence to customers," said Blue. "Built from our existing integrated network of proven systems and subsystems, Quadratix is GA's end-to-end solution for providing information dominance."For information about Quadratix, go to https://quadratix.ga.com .About General AtomicsGeneral Atomics is a defense and diversified technologies company, founded in 1955 as a division of General Dynamics and acquired by the Blue family in 1986. GA and affiliated companies operate on five continents. GA and affiliates produce unmanned aircraft and airborne surveillance systems, satellite surveillance, electro-magnetic rail gun, high-power laser, hypervelocity projectile, and power conversion systems. GA is a leader in nuclear fusion research, next-generation nuclear fission and advanced materials technologies. The company occupies 8+ million square feet of engineering, laboratory and manufacturing facilities and comprises over 13,000 employees.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.comSOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
HighTide Therapeutics Announces Publication of Phase 2 Study of Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes Mellitus in JAMA Network Open ACN Newswire

HighTide Therapeutics Announces Publication of Phase 2 Study of Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes Mellitus in JAMA Network Open

2025-03-05
– Data from the proof-of-concept study showed berberine ursodeoxycholate was generally well tolerated and had beneficial therapeutic effect in improving glycemic, hepatic and cardiometabolic parameters– The multifaceted effects demonstrated by berberine ursodeoxycholate support this new molecular entity as a unique oral treatment option for T2DM and its comorbidities– T2DM phase 3 data readout is expected to be announced in the first half of 2025ROCKVILLE, MD and SHENZHEN, Mar 4, 2025 - (ACN Newswire via SeaPRwire.com) – HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic liver and metabolic diseases, today announced that data from the Phase 2 proof-of-concept study evaluating berberine ursodeoxycholate (HTD1801) for the treatment of type 2 diabetes mellitus (T2DM) was published online in JAMA Network Open. The publication reports results of the randomized, placebo-controlled 12-week study to assess efficacy, safety and tolerability of HTD1801 compared to placebo in patients with T2DM. The trial achieved its primary endpoint by demonstrating a statistically significant and superior reduction in HbA1c at week 12 with HTD1801 versus placebo. A majority of patients treated with HTD1801 achieved target HbA1c
More